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1. Introduction 
The result of this thesis is proposing an important role of the peroxisomal compartment in 
macrophages within inflammatory processes. It is based on previous findings of members of 
the Institute for Anatomy and Cell Biology, Department II, Medical Cell Biology, Justus-
Liebig University, Gießen. The published studies link impaired peroxisome function with 
increased oxidative stress in inflammatory neuronal tissue and documented for the first time 
the presence of peroxisomes in alveolar macrophages [1]. A careful literature research at the 
beginning of this thesis revealed that there was only scarce knowledge about the role and 
function of peroxisomes in macrophages during inflammatory processes. Consequently, we 
searched if inflammatory stimuli affect the peroxisomal compartment in macrophages and 
what implications for the inflammatory response may emerge from impaired peroxisome 
function.  
1.1 Peroxisomes 
General aspects 
Peroxisomes can be found in nearly all eukaryotic cells. For the first time they were described 
by Rhodin in 1954 who introduced the term “microbodies” [2], while their first biochemical 
characterisation was done in 1966 by De Duve and Baudhuin, who coined the name 
peroxisomes to these organelles, related to their content of hydrogen peroxide (H2O2) 
producing and degrading enzymes [3].  
Peroxisomes are subcellular organelles surrounded by a single membrane and contain no own 
genome unlike mitochondria [4]. Shape, size (0.1-1.0 µM), number and metabolic functions 
of peroxisomes differ between different organism, organs and cell types [5]. Recent findings 
propose an Actinobacteria origin of the peroxisome. The study indicates a transfer of 
peroxisomal genes to the nucleus. During this process, peroxisomal genes were lost and got 
replaced by mitochondrial genes with similar function [6]. This could explain the unique 
peroxisome targeting and peroxisome protein import in comparison to the protein import of 
mitochondria or chloroplasts. Peroxisomes have the capability to import folded functional 
matrix proteins, proteins with attached cofactors and oligomerised matrix proteins into the 
organelle [7]. Consequently, the peroxisomal import machinery is able to transport larger 
cargo across the organelle membrane than mitochondria or chloroplasts.  
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According to their broad range of catabolic and anabolic functions, they are a multipurpose 
organelle, a kind of “Swiss army knife” (for a review see [8]). Additionally, peroxisomes 
have the capability to adapt to nutritional or environmental stimuli/changes [9]. At the 
moment more than 130 peroxisomal proteins are known [10]. Moreover, more than 30 so 
called peroxin (PEX…p) proteins have been discovered, 14 of them in mammals. Those with 
no homologues in mammals were discovered mainly in yeasts [8]. PEX proteins play an 
important role in peroxisomal biogenesis (for an overview see Tab. 1) and function. They are 
involved in peroxisomal matrix protein import. Dependent on their function, they are 
integrated into or attached to the peroxisomal membrane, cycle between peroxisomal 
membrane and the cytosol or are located in the peroxisomal matrix 
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Tab. 1: discovered peroxins and their characteristics. 
Peroxin Characteristics 
Organism 
Mammals Yeasts Plants Fungi 
PEX 1  ATPase of the AAA-family x x x x 
PEX 2 
zinc binding integral peroxisomal membrane protein, contains 
C3H4-motive 
x x x x 
PEX 3 
integral peroxisomal membrane protein,  
membrane protein import  
x x x x 
PEX 4 peroxisome associated ubiquitin conjugating enzyme (E2) x x x - 
PEX 5 
PTS1-Receptor,  
located in cytoplasm and associated at the outside of 
peroxisomal membrane  
x x x x 
PEX 6 ATPase of the AAA-family x x x x 
PEX 7 
PTS2-Receptor,  
located in cytoplasm and associated at the outside of the 
peroxisomal membrane 
x x x x 
PEX 8 peripheral peroxisome membrane protein  - x - x 
PEX 9 integral peroxisomal membrane protein - x - - 
PEX 10 
zinc binding integral peroxisomal membrane protein, contains 
C3H4-motive 
x x x x 
PEX 11 
integral peroxisomal membrane protein,  
involved in fission processes 
x x x x 
PEX 12 
zinc binding integral peroxisomal membrane protein, contains 
C3H4-motive 
x x x x 
PEX 13 
integral peroxisomal membrane protein,  
contains SH3-domaine,  
part of the matrix protein receptor docking complex,  
binds Pex5p, Pex7p, Pex14p 
x x x x 
PEX 14 
peroxisomal membrane protein,  
class II binding motive for SH3-ligands,  
part of the matrix protein receptor docking complex,  
binds Pex5p, Pex7p, Pex13p 
x x x x 
PEX 15 integral peroxisomal membrane protein - x - - 
PEX 16 
integral peroxisomal membrane protein,  
necessary for membrane biogenesis 
x x x x 
PEX 17 peripheral membrane, binds Pex14p - x x - 
PEX 18 
mainly cytosolic, necessary for PTS2 import,  
highly homologue to PEX21 
- x - - 
PEX 19 
farnesylated protein, binds Pex3p,  
located in cytoplasm and associated at the outside of 
peroxisomal membrane 
x x x x 
PEX 20 
cytosolic protein,  
necessary for dimerisation and import of Fox3p 
- x - x 
PEX 21 
cytosolic protein,  
necessary for PTS-2 mediated protein import,  
highly homologue to PEX18 
- x - - 
PEX 22 
integral peroxisomal membrane protein,  
interacts with Pex4p 
- x x x 
PEX 23 integral peroxisomal membrane protein - x - x 
PEX 24 integral peroxisomal membrane protein - x - x 
PEX 25 
localised at the peroxisome,  
regulates peroxisome number and size 
- x - - 
PEX 26 
peroxisomal membrane protein,  
recycling of the PTS-1 receptor Pex5p 
x - - x 
PEX 27 
localised at the peroxisome,  
regulates peroxisome number and size 
- x - - 
PEX 28 
integral peroxisomal membrane protein,  
involved in dynamic processes of the peroxisome 
- x - - 
PEX 29 
integral peroxisomal membrane protein,  
involved in dynamic processes of the peroxisome 
- x - - 
PEX 30 localised at the peroxisome, regulates peroxisome size - x - - 
PEX 31 localised at the peroxisome, regulates peroxisome size - x - - 
PEX 32 localised at the peroxisome, regulates peroxisome size - x - - 
PEX 33 peroxisomal docking complex - - - x 
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1.1.1 Peroxisomal protein import and biogenesis 
Up to now, peroxisomal protein import has been studied in yeasts and mammals. Peroxisomal 
proteins are synthesised at free ribosomes in the cytoplasm. The peroxisomal shuttling 
mechanism includes Pex5p and Pex7p [11, 12]. Pex5p is the binding partner of proteins 
directed to peroxisomes. Most of these proteins contain a specific targeting sequence at their 
carboxy-terminal end, the peroxisomal targeting sequence-1 (PTS-1). Historically, the PTS-1 
is composed of the following consensus sequence (S/A/C) - (K/R/H) - (L/M). Since amino 
acid residues further up- or downstream of the original tripeptide influence the receptor 
binding capacity of the cargo protein, Brocard et al. proposed to define the PTS-1 as a 
dodecamer sequence recently [13]. In contrast, few peroxisomal proteins contain the amino-
terminal PTS-2. The PTS-2 signal is more common in plants, whereas in C. elegans and C. 
briggsae PTS-2 dependent protein import seems to be completely absent [11, 12]. The 
consensus sequence is a degenerated nonapeptide: 
(R) - (L/V/I/Q) – xx - (L/V/I/H) - (L/S/G/A) – x - (H/Q) - (L/A) 
Pex7p recognises PTS-2 containing proteins. After the Pex7p-guided transport, the cargo 
protein gets cleaved during import by a peroxisomal matrix protein [14, 15]. 
During the PTS-1 initiated transport process, conformational changes of Pex5p at its N-
terminus are induced after cargo binding, leading to interaction of the Pex5p/cargo complex 
with the import machinery at the peroxisomal membrane [12]. The import machinery consists 
mainly of Pex13p, Pex14p as well as the zinc RING finger proteins Pex2p, Pex10p and 
Pex12p [14]. Two hypotheses of cargo delivery are proposed. Either a complete transition of 
the Pex5p into the peroxisomal matrix (“extended shuttle hypothesis”) is suggested [16] or it 
is proposed, that Pex5p remains outside of the peroxisomal matrix, attached to the 
peroxisomal import machinery (“shuttle hypothesis”). 
In humans two isoforms of Pex5p are known. These represent distinct splicing variants. The 
short form, Pex5S is exclusively involved in PTS-1 cargo-protein binding and transport. The 
long variant, Pex5L is also involved in targeted PTS-2 cargo protein transport. Pex5L 
initialises the binding of the transporter complex with the protein import machinery at the 
peroxisomal membrane by forming a complex with Pex7p and the corresponding cargo 
protein [15, 16]. In S. cerevisiae Pex18p and Pex21p and in fungi Pex20p play a similar role 
in cargo protein transport [17]. For an overview of peroxisomal matrix protein import and 
peroxisomal membrane protein import see Fig. 1. 
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Fig. 1 Peroxisomal biogenesis according to Platta and Erdmann. 
A) The cytoplasmic receptor Pex5p recognizes PTS-1 containing peroxisomal matrix proteins and guides 
them to the peroxisomal membrane. After docking at the sophisticated import complex (consisting of 
Pex17p, Pex14p, Pex13p and Pex8p) target proteins are imported while Pex5p is recycled by a complex 
containing Pex2p, Pex10p and Pex12p. B) New synthesized PMPs are guided and transported to the 
peroxisomal membrane by Pex19p. Integration into the peroxisomal membrane is Pex16p/Pex3p mediated, 
while Pex19p is recycled into the cytoplasm. 
 
 
Integration of peroxisomal membrane proteins (PMPs) into the membrane of pre-existing 
peroxisomes is necessary for peroxisomal biogenesis. In mammals, fungi and plants the 
import complex consists of Pex19p, Pex3p and Pex16p (see Tab. 1 and Fig. 1) [13, 18]. In 
Yeasts (except Yarrowia lipolytic) and in Caenorhabditis spec. Pex16p seems to be absent 
[19]. PMPs originate from free cytoplasmic ribosomes. They contain a membrane targeting 
sequence (mPTS) with an inbuilt Pex19p-binding site and either a transmembrane domain or 
a protein binding site for membrane anchoring [14]. Pex19p is thought to be a protein 
receptor, cycling between cytoplasm and peroxisome. It binds PMPs in the cytoplasm, guides 
the PMPs to the peroxisomal membrane and interacts with Pex3p and Pex16p for PMP 
insertion [19, 20]. Loss of any of these three Pex proteins leads to a complete loss of 
peroxisomal membranes. It was hypothesised that the reintroduction of these proteins in 
appropriate knock out cells leads to the formation of peroxisomes de novo out of the ER [21, 
22]. 
Peroxisomes do not only increase in size by import of matrix and membrane proteins but also 
proliferate by division which is induced by a broad variety of stimuli. The Pex protein Pex11p 
is involved in these processes, since deletion of PMP27, the yeast homologue of Pex11p, 
leads to significant reduction in peroxisome abundance, while over-expression showed a 
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massive increase of peroxisome abundance [20]. In mammals three isoforms of the Pex11p 
family are known (Pex11p, Pex11pβ and Pex11p) that are thought to form homo-oligomers 
[21]. Yeast species harbour only a single Pex11p but contain several additional fission related 
proteins (Pex23p-Pex25p, Pex27p-Pex32p) (see Tab. 1). It was hypothesised, that 
oligomerisation might be a regulatory mechanism of Pex11p activity. Recently, Knoblach et 
al. showed in S. cerevisiae a phosphorylation dependent regulation of Pex11p [22]. For 
regular peroxisome division, further proteins are necessary, e.g. the dynamin-like large 
GTPase (DLP-1), its receptor Fis-1 and the mitochondrial fission factor (MFF) [23]. It is very 
noteworthy, that in mammals these proteins are involved in peroxisomal as well as 
mitochondrial division [24, 25]. Furthermore, in yeast, in fungi and in plants, dynamin-like 
GTPases and Fis-homologues are shared in peroxisomal and mitochondrial division [25-27].  
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1.1.2 Peroxisomes in cellular metabolism 
Depending on organism, organ and cell type, peroxisomes are involved in a variety of distinct 
anabolic and catabolic processes, such as degradation of reactive oxygen species (ROS),  
β-oxidation of a broad set of lipid derivatives and -oxidation of branched-chain fatty acids 
[28], as well as the biosynthesis of cholesterol, plasmalogens, phospholipids, isoprenoids, 
xenobiotics, pristanic acid and bile acids (see Tab. 2) [29-31]. Additionally, peroxisomes are 
involved in the glyoxylate cycle in plants [32], whereas they take part in penicillin 
biosynthesis in some fungi [33]. 
 
Tab. 2 Overview of metabolic activities in peroxisomes, according to Titorenko et al. [34] 
Species anabolic catabolic 
Yeast  Lysine 
Methanol, β-oxidation of FA 
degradation of H2O2, glyoxylate cycle 
Fungi  Penicillin 
β-oxidation of FA, degradation of H2O2 
glyoxylate cycle 
Plant   
Purine, reactions in photorespiration, 
β-oxidation of FA, degradation of H2O2 
glyoxylate cycle 
Mammals 
Etherlipids 
Plasmalogens 
Cholesterol 
Bile acids 
Poly unsaturated fatty acids (PUFA) 
Amino acids, Purine, Polyamine 
α-oxidation of FA 
β-oxidation of distinct lipid derivates, 
degradation of ROS (e.g. H2O2) 
Human  
Etherlipids 
Plasmalogens 
Cholesterole by -oxidation enzymes 
Bile acids     by -oxidation enzymes 
PUFA           by -oxidation enzymes 
Amino acids, Purine, Polyamine 
α-oxidation FA, β-oxidation of distinct 
lipid derivatives, degradation of ROS 
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1.1.3 Peroxisomes in ROS metabolism 
As shown above, peroxisomes are involved in metabolic processes in which H2O2 is formed 
as by-product.  
Fig. 2 gives an overview of the processes related to ROS production and degradation in 
peroxisomes. Main sources of H2O2 in peroxisomes are flavin oxidase activity (e.g. FA β-
oxidation), dispropotionation of superoxide radicals and in plants the photorespiratory 
glycolate oxidase reaction (see Tab. 3) [35]. H2O2 is highly reactive and causes severe damage 
in all parts of the cell. To prevent intracellular damage, peroxisomes contain a large set of 
ROS degrading enzymes summarized in Tab. 4 [35].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Overview of ROS producing and degrading processes in peroxisomes. 
Modified, according to Schrader and Fahimi, related enzymes are elucidated in Tab. 3 and Tab. 4 
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Tab. 3 ROS generating enzymes in peroxisomes 
Enzyme Substrate ROS 
(1) Acyl-CoA oxidases in rodents   
(a) Palmitoyl-CoA oxidase (ACOX1) Long chain fatty acids H2O2 
(b) Trihydroxycoprostanoyl-CoA 
oxidase (ACOX 2) 
Bile acid intermediates H2O2 
(c) Pristanoyl-CoA oxidase (ACOX3) Methyl branched chain fatty acids H2O2 
(2) Urate oxidase  Uric acid H2O2 
(3) Xanthine oxidase  Xanthine H2O2, O2
·− 
(4) D-amino acid oxidase  D-Proline H2O2 
(5) Pipecolic acid oxidase  L-Pipecolic acid H2O2 
(6) D-aspartate oxidase D-aspartate N-Methyl-D-aspartate H2O2 
(7) Sarosine oxidase Sarcosine, pipecolate H2O2 
(8) L-alpha-hydroxy acid oxidase  Glycolate, lactate H2O2 
 (9) Poly amine oxidase N-Acetyl spermine/spermidine H2O2 
(10) inducible nitric oxide synthase (iNOS) L-Arginine
 ·
NO 
(11) Plant sulfite oxidase  Sulfite H2O2 
 
 
Tab. 4 ROS degrading enzymes in the cell  
Enzyme Substrate Cellular localisation 
(1) Catalase  H2O2 Cytoplasm, nucleus, peroxisome  
(2) Glutathione peroxidase 1 H2O2 All cell compartments (not lysosomes) 
(3) Cu, Zn SOD  O2
·−
 Cytoplasm, peroxisomes, nuleus 
(4) Epoxide hydrolase  Epoxides ER, cytoplasm and peroxisomes 
(5) Peroxiredoxin I  H2O2 Cytoplasm, nucleus, mitochondria, peroxisomes 
(6) Peroxiredoxin V (PMP20) H2O2 Peroxisomes 
(7) Plant ascorbate–glutathione cycle H2O2 
Peroxisomes, chloroplasts, cytoplasm,  
root nodule mitochondria (plants only)  
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1.1.4 Peroxisomes in lipid metabolism 
1.1.4.1 Peroxisomal β-oxidation 
Peroxisomes contain different anabolic and catabolic functions, like degradation of saturated 
and unsaturated medium, long- and very long-chain fatty acids and their derivates (e.g. α-
oxidation, β-oxidation), synthesis of cholesterol, ether-phospholipids and polyunsaturated FA 
as well as leukotriens and prostaglandins, xenobiotics, and pristanic acid [5, 28, 31, 38-41]. 
The most prominent and best investigated pathway in peroxisomal metabolism is the 
degradation of fatty acids (FA). In mammals, FA-degradation is divided in a mitochondrial 
and a peroxisomal part both exhibiting different substrate specificities for FA degradation. 
The substrates of mitochondrial β-oxidation are limited to short (<C8), middle (C8-C12) und 
long chain FA (≤C20) In contrast substrates for peroxisomal β-oxidation are much more 
versatile including very long-chain FA (VLCFA, >C22), long- and medium-chain 
dicarboxylic FA (products of microsomal ω-oxidation) [28], prostaglandins, leukotriens, 
cholesterol side chain and steroids [5]. Therefore, the β-oxidation machinery in mitochondria 
and peroxisomes differ in their enzyme composition [42-46]. This division of tasks seems to 
be present mainly in mammals. In lower organisms like yeasts and plants FA β-oxidation is 
performed almost exclusively in peroxisomes [47].  
Before degradation, FA are activated by binding to acyl-CoA which is a substrate specific 
reaction mediated by different acyl-CoA-synthetases [48]. In mammalian mitochondria the 
VLCFA related acyl-CoA-synthetase is missing [49], whereas it is present on the peroxisomal 
membrane. Peroxisomal import of VLCF acyl-CoA derivatives is thought to be mediated by 
peroxisomal ATP-binding-cassette transporter (ABC-transporter). ABC-transporter belong to 
the half adenosinetriphosphate transporter category D sub-family (ABCD). In mammals four 
family members are known. ABCD1 (adrenoleukodystrophy protein, ALDP), ABCD2 (the 
adrenoleukodystrophy-related protein, ALDRP), ABCD3 (the 70-kDa peroxisomal membrane 
protein PMP70) and ABCD4 (the PMP70-related protein P70) [50-53]. Data from the 
literature show, that most of the half transporters form dimers, it is hypothesized that this is 
also the case for peroxisomal ABCD-transporter [54]. 
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Fig. 3 Schematic overview of peroxisomal β-oxidation. 
In peroxisomes very long chain fatty acids (VLCFA) and branched chain fatty acids are degraded. Left: 
degradation of straight chain VLCFA (e.g. cerotic acid) and degradation of branched chain fatty acid (e.g. 
phytanic acid). Right: peroxisomal β-oxidation step by step. ACOX I/II acyl-CoA oxidase I/II, DBP D-
bifunctional protein, LBP L-bifunctional protein, thiolase 3-oxoacyl-CoA thiolase, SCPx  
Sterol carrier protein X 
 
Basically, β-oxidation in mitochondria and peroxisomes consists of the same four subsequent 
steps: dehydrogenation, hydration, second dehydrogenation and thiolytic cleavage of acetyl-
CoA. In humans, the rate limiting first step in β-oxidation is executed by either acyl-CoA-
oxidase I (ACOXI, specific for straight chain VLCFA) or acyl-CoA-oxidase II (ACOXII, 
specific for CoA-esters of 2-methyl branched-chain fatty acids) [55, 56]. During this reaction 
electrons are transferred via FADH2 to molecular oxygen. H2O2 is generated as by-product 
and is detoxified by catalase. The following two steps (hydration and second dehydration) are 
catalysed by two distinct bifunctional proteins (containing enoyl-CoA hydratase and  
3-hydroxy-acyl-CoA dehydrogenase activity) which differ in their substrate specificity.  
D-bifuntional protein/enzyme (DBP/DBE) prefers VLC- and branched chain FA [57], 
whereas L-bifunctional protein/enzyme (LBP/LBE) sequesters also LCFA [58]. During the 
last step, one molecule of acetyl-CoA is detached from the activated FA by thiolytic cleavage. 
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For this purpose human peroxisomes contain two different 3-ketoacyl-CoA-thiolases. The 
straight-chain 3-oxoacyl-CoA thiolase (ACAA1) for 3-keto-acyl-CoA esters of VLCFA and 
the sterol carrier protein X (SCPx) for e.g. 2-methyl FA and 3-keto-acyl-CoA-esters of 
pristanic acid [59]. Three thiolases are described in rat and mouse: 3-ketoacyl-CoA thiolase A 
and B, a sterol carrier protein-2/3-ketoacyl-CoA thiolase (ScpX) as well as a thiolase involved 
in cholesterol synthesis [60, 61]. In mammals peroxisomal β-oxidation degrades FA down to 
a length of 6-8C followed by a transfer to mitochondria in form of carnitine-esters [62] or as 
free FA [63], for further degradation and ATP-production.  
1.1.4.2 Peroxisomal -oxidation 
A special group of FA, 3-methyl branched FA carry a methyl group at their βC. Prior to 
peroxisomal β-oxidation, they have to undergo peroxisomal -oxidation. During this process 
the first carbon atom is cleaved off and is released as CO2 and the methyl group in the 
shortend derivative is then located at the C position. Thereafter, the acyl-CoA FA is subject 
to peroxisomal β-oxidation. The most prominent representative of this group of FA in human 
physiology is phytanic acid. It is a degradation product of chlorophyll in ruminantia. Phytanic 
acid is obtained through the consumption of dairy products, especially milk and other 
ruminant animal fats. At the outside of peroxisomes phytanic acid is modified to its activated 
form phytanoyl-CoA by an acyl-CoA synthetase [64, 65]. After import into the peroxisomal 
matrix the phytanoyl-CoA is hydrolized by phytanoyol-CoA hydroxylase to  
2-hydroxyphytanoyl-CoA [66]. Thereafter, 2-hydroxyphytanoyl-CoA lyase cleaves the 
intermediate to pristanal and formyl-CoA [67-69]. Finally, an aldehyde-dehydrogenase in 
peroxisomes catalyses pristanal to pristanic acid, which is further degraded by peroxisomal  
β-oxidation [70].  
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1.1.5 Peroxisomes and peroxisome proliferator-activated receptors 
Peroxisomes play a substantial role in different metabolic pathways [63]. Impaired 
peroxisomal gene function leads to diseases of the Zellweger- or X-ALDP- spectrum. 
Furthermore, peroxisomes are involved in cellular defense against peroxides and ROS [71]. 
Ahlemeyer et al. have demonstrated that impaired peroxisomal function is linked to an 
increased ROS levels and inflammatory state in mouse brain which points out to a possible 
role of peroxisomes in chronic neurodegenerative diseases [72]. Therefore, the abundance and 
metabolism of peroxisomes and peroxisomal proteins has to be tightly regulated. Peroxisome 
proliferator-activated receptors (PPARs) are important regulators of peroxisomal abundance 
and metabolism. Until now, three distinct PPARs (PPARα, β/δ and γ) have been discovered. 
PPARs belong to the superfamily of steroid hormone receptors [73]. PPARα, -β/δ and -γ 
regulate a wide range of genes by ligand-dependent transcriptional gene activation and 
repression, fulfilling distinct functions in different tissues. Each PPAR has a characteristic 
tissue distribution. 
 PPARα (alpha) is expressed in tissues with a high catabolic rate of fatty acids, such as 
brown and white adipose tissue. Furthermore in liver, kidney, heart, skeletal muscle 
and the retina [74, 75].  
 PPARβ/δ (beta/delta) is ubiquitously expressed. Markedly in brain, kidney, liver, 
pancreas, heart, spleen and adipose tissue [74, 75]. 
 PPARγ (gamma): Two forms of PPARγ are known, PPARγ1 and PPARγ2. They 
originate from the same gene but contain different promoters and 5´exons. PPARγ1 is 
ubiquitously expressed, while PPARγ2 is mainly located in adipose tissue. (for review 
see [76]).  
PPARs are predominantly located in the cytoplasm. After activation through a corresponding 
ligand, they dissociate from a corepressor, recruit coactivators, heterodimerise with other 
members of the nuclear receptor superfamily (like the retinoid X receptor) and translocate into 
the nucleus. There they recognise target DNA sequences, so called PPAR response elements 
(PPREs) and influence target gene transcription [77]. Ligands of PPARs are native FA, 
modified FA, metabolites and intermediates of FA metabolism [78]. Activation of PPARγ is 
an important therapeutic mechanism of antidiabetic drugs called thiazolidinediones (TZDs).  
Additionally, PPARs influence the peroxisomal metabolism, since peroxisomal genes contain 
PPRE and are regulated by PPARs [79]. Moreover, recent data of our group suggest an 
important role of peroxisomes in balancing PPAR ligand homeostasis, since peroxisomes 
degrade PPAR ligands.  
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Besides their role in energy homeostasis, PPARs are involved in the regulation of the 
inflammatory response in monocytes/macrophages. Especially PPARα and -γ have been 
described in immunoregulatory cells, such as macrophages (MΦ) [80-82]. However, it is 
difficult to draw a conclusion about the role of distinct PPARs in inflammation, since they 
have shown pro-inflammatory as well as anti-inflammatory effects in different studies. 
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1.2 Macrophages 
The first description of Macrophages (MΦ) (Greek: "large eaters") was in 1893 by the russian 
microbiologist Ilya Ilyich Mechnikov, who studied and worked several years in Gießen [83]. 
Depending on the blood building during ontogenesis of individuals, the origin of monocytes 
lies either in the yolk sac (embryo), the liver and spleen (foetus and newborn) or in the bone 
marrow [84]. Monocytes derive from pluripotent haematopoetic stem cells called colony-
forming unit of the granulocyte and monocyte lineage (CFU-GM). Monocytes/MΦ are part of 
the innate immune system. They recognise, capture and destroy invading pathogens such as 
bacteria, pathogenic protozoa and fungi. Additionally, they are able to identify and neutralise 
tumour cells, virus-infected cells or apoptotic cells [85, 86]. Finally, monocytes and MΦ play 
an important role in humoral and cell mediated immune responses, as mediators between the 
innate and the adaptive immune system, since they are able to phagocyte invading pathogens 
and to present antigens to other cells of the adaptive immune system [87].  
 
1.2.1 Development 
During their development, monocytes differentiate progressively from monoblasts into 
promonocytes and monocytes within the bone marrow. At this developmental stage, 
monocytes leave the bone marrow into the peripheral blood stream and mature to MΦ (in 
tissue) [88]. Monocytes and MΦ comprise the mononuclear phagocyte system. During MΦ 
development, the differentiating hematopoetic stem cells lose their pluripotency and gain 
monocyte and MΦ specific features, such as the expression of IgG- and C3-receptors, 
phagocytotic activity, increasing lysosome abundance and transient peroxidase activity (see 
Fig. 4) [89-92]. The development from stem cells to MΦ requires the availability of growth 
factors, like the macrophage colony-stimulating factor (M-CSF/CSF-1), the granulocyte-
macrophage colony-stimulating factor (GM-CSF), interleukin-1, -3, -6 (IL-1, -3, -6) and 
interferon-γ (IFNγ) [93-97]. 
Under physiological conditions, a small percentage of monocytes leave the blood stream and 
enter the surrounding tissue and differentiate into resident MΦ, remaining in the tissue for 
several months [98]. During bacterial/viral infection, injury and/or inflammation, the 
production of monocytes in the bone marrow is increased and monocytes are attracted out of 
the blood stream into the affected tissue or organ due to the enhanced local expression and 
secretion of cytokines and chemoattractants [99]. Because of the stimulating cocktail of 
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growth factors, cytokines and chemokines monocytes differentiate into MΦ and abolish the 
cause of infection/inflammation. 
 
 
Fig. 4 Differentiation and characteristics of mononuclear phagocytic cells during development. 
Origin and localisation of developing macrophages. The lower part exemplifies the gain and loss of typical 
features during development. According to Burke et al., 2002 [100]. 
 
Another important role of MΦ is the regulation of tissue-homeostasis. During embryogenesis, 
MΦ clear apoptotic areas, such as the skin between digits, coordinate organogenesis. The 
regulation of tissue-homeostasis persists in adult tissue, since MΦ are involved in wound 
healing, tissue repair and bone or organ remodelling [101-104]. Furthermore, MΦ participate 
in lipid homeostasis, e.g. cholesterol-metabolism [105] and in surfactant degradation in lungs 
[1]. 
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1.2.2 Macrophages in bacterial Infection 
In this chapter the composition of LPS will be described. Most of pathogenic bacteria in 
humans are gram-negative. MΦ detect these pathogens mainly based on the recognition of a 
unique component of the bacterial outer cell membrane, called lipopolysaccharide (LPS). LPS 
is a ligand of the CD14/Toll-like-receptor-4(TLR-4)/MD2 complex at the MΦ membrane. 
Ligand–complex interaction and signal transition by this receptor will be described in the 
chapter “the TLR family”. Lipopolysaccharide is a highly conserved component of the 
bacterial membrane and crucial for cellular integrity of the bacteria, since loss of LPS leads to 
bacterial death [106]. LPS consists of three covalently linked units (see Fig. 5). The 
hydrophobic lipid A is the innermost unit of LPS, anchoring the LPS to the outer bacterial 
membrane. Lipid A consists of two glucosamine units with attached FAs and contains 
normally one phosphate group on each carbohydrate [107]. The central part of LPS consist of 
a core oligosaccharide (consisting of two subunits, an outer and an inner core), a short chain 
of sugar residues, which is highly diverse among bacterial species and  
 
 
 
 
 
 
 
 
Fig. 5 Structure of LPS. 
 
even within strains of species [108] and an O-antigenic side chain, a repetitive glycane 
polymer. This O-antigen is attached to the core oligosaccharide and comprises the outermost 
domain of the LPS molecule.  
After LPS detection by TLR-4, resident MΦ induce a defensive response by attracting and 
activating other immune cells, including the recruitment of blood monocytes [109]. MΦ 
produce a massive amount of reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), that is called oxidative burst [110, 111]. When activated, MΦ phagocyte [112-114] 
and digest pathogens [115, 116]. Moreover, MΦ secrete a variety of pro- and anti-
inflammatory cytokines, modulating the host response to bacterial infection upon LPS 
stimulation (see Tab. 5 for details) [117, 118]. 
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Tab. 5 MΦ secretory products in bacterial defence 
Product Function Reference 
Interleukine-1 (IL-1)
 proliferation and differentiation of T and B cells, 
 IL-2, -8 and CSF production, 
[119] 
TNF
 IL-6, -8, 9 and CSF production
 CR3 
[120] 
IL-6 Blocks LPS induced IL-1 and TNF production [121] 
IL-8
 neutophil and monocyte activation 
chemotaxis 
[122] 
ROS/RNS Killing bacteria by attacking lipids, proteins and DNA [110, 111] 
Lysozyme Perforating the bacterial membrane [123] 
Complement factors Opsonising bacteria for phagocytosis [124] 
 
1.2.3 The TLR family 
The toll-like receptor 4 (TLR-4) is responsible for LPS recognition in monocytes/MΦ. TLR-4 
belongs to the pattern recognition receptor (PRRs) superfamily and to the group of type I 
transmembrane proteins [125,126]. The receptor consists of three distinct domains. The outer 
domain contains leucine-rich repeats, which mediate the recognition of pathogen-associated 
molecular patterns (PAMP). The middle domain is a transmembrane domain, connecting the 
inner and outer domain. The inner domain is the Toll-IL receptor (TIR) domain, necessary for 
TLR dependent signal transduction [127]. Up to now, 13 different TLR family members have 
been discovered in mammals [128]. Their location within the cell differ as well as their ligand 
preferences (see Tab. 6), covering a broad spectrum of components of foreign pathogens 
referred to as PAMPs [125, 129]. In addition, endogenous ligands, such as heat shock proteins 
(HSPs), hyaluronate and heparan sulfate (extracellular matrix breakdown products), 
fibronectin, the high mobility group box 1 protein (HMGB1) and oxidised low-density 
lipoproteins (oxLDL) are known ligands for TLRs [130].  
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Tab. 6 Human TLRs, ligands and distribution (according to Kawai rt al. [127]) 
Receptor Ligand(s) Localisation 
TLR-1 Triacyl lipopeptides, mycoplasma Cell membrane 
TLR-2 
Diacyl lipopeptides from bacteria, peptidoglycan and lipoteichoic acid from 
Gram-positive bacteria, lipoarabinomannan from mycobacteria, zymosan from 
fungi, tGPI-mucin from Trypanosoma cruzi and the hemagglutinin protein from 
measles virus. 
Cell membrane 
TLR-3 dsRNA Endosome 
TLR-4 LPS Cell membrane 
TLR-5 flagellin Cell membrane 
TLR-6 forms heterodimer with TLR1 or TLR-2 Cell membrane 
TLR-7 ssRNA Endosome 
TLR-8 Viral ssRNA Endosome 
TLR-9 unmethylated 2′-deoxyribo (cytidine-phosphate-guanosine) (CpG) DNA motifs Endosome 
TLR-10 unknown Cell membrane 
TLR-11 uropathogenic bacterial components (profiling) Cell membrane 
TLR-12 unknown Unknown 
TLR-13 unknown Unknown 
 
1.2.4 TLR-4 mediated signal transduction 
As stated above, several different proteins (CD14, TLR-4, MDR2) are involved in LPS 
recognition. Moreover, the binding of LPS and the LPS-mediated signal transduction 
including alterations of gene transcription is a multistep process which is illustrated in Fig. 6. 
1) LPS is bound by the LPS binding protein (LBP), a soluble protein in the interstitium.  
2) The LPS/LBP interaction facilitates the binding of this complex to the membrane 
anchored CD14 molecule. 
3) CD14 transfers the LPS/LBP-complex to TLR-4. A further soluble protein, MD-2, is 
associated to TLR-4, allowing the homodimerisation of TLR-4 after LPS binding 
[131]. 
4) Homodimerisation of TLR-4 is necessary for the early phase of the LPS-response via 
recruitment of TIR-domain containing adaptors (TIRAP) and subsequently MyD88. 
The early phase changes cellular gene transcription within minutes. 
5) Signal transduction via recruitment of the IL-1 receptor-associated kinase (IRAK) and 
the TNF receptor-associated factor 6 (TRAF6) leads to activation of the nuclear 
transcription factor NFB and the activating protein 1 (AP-1), inducing the 
transcription of pro-inflammatory cytokines, such as IL-6 and TNF. 
6) The late phase LPS response is induced after long term LPS exposure. The receptor 
complex LPS/LBP/CD14/TLR-4/MD-2 gets internalised, forming endosomes. Signal 
transduction is mediated by translocation of the associated membrane protein (TRAM) 
and the Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF) 
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recruitment . The following activation of NFB leads to the activation of interferon 
regulatory factors (IRNs) [133]. 
By this two phase multistep LPS-response, a highly regulated pro-inflammatory cellular 
response is generated, leading to drastic morphologic changes, antimicrobial activity 
(oxidative burst), release of TNF and other inflammatory cytokines for auto- and paracrine 
cellular communication. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 TLR-4 mediated signal transduction. 
After LPS binding by LBP (1), CD14 forms with LPS/LBP and TLR-4, MD-2 a complex which induce 
TLR-4 homodimerisation (2-4). The activated TLR-4 homodimer recruits successively the adaptor proteins 
TIRAP, MyD88, IRAK and TRAF6 (4, 5) leading to activation of transcription factors (e.g. NFB, AP-1), 
initiating the early inflammatory response. Persisting LPS signalling leads to internalisation of the TLR-4 
complex into endosomes and recruitment of TRAM and TRIF (6) and the initiation of the late response, 
activating transcription factors (e.g. NFB). 
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1.2.5 TNF signalling 
First description of TNF was in 1975. Application of TNF caused tumour necrosis after 
LPS induction in a sarcoma mouse model [134]. Since then, the knowledge  
 
 
Fig. 7 TNF signalling.  
TNF and TNFR-1 are trimers. 1) binding of TNF to TNFR-1 leads to conformational changes of its 
cytoplasmic death domain (DD). 2) These changes allow the recruitment of adaptor proteins, that determine 
the cellular reactions to the TNF, either the induction of an inflammatory response or leading to apoptosis. 
In both pathways, TRADD and RIP are recruited. A further recruitment of TRAF2/5 and cIAP induce the 
activation of the p38 and the JNK MAP-kinase pathways as well as activation of NFB-dependent 
transcription of pro-inflammatory genes. In contrast, recruitment of FADD induces cleavage of procaspase-
8, followed by cleavage of the execution caspase-3 leading to apoptosis. 
 
about TNF and its mediated effects has been grown continuously. Two TNF receptors are 
known, TNF receptor (TNFR)-1 and -2. TNFR-1 is involved in proliferation, inflammation 
and apoptotic signalling [135], while TNFR-2 is involved in tissue repair and angiogenesis 
[136, 137] but is less well characterised. Both receptors belong to the TNF receptor 
superfamily [138]. Family members are characterised by one to six cysteine rich repeats at 
their extracellular domain [139]. TNFR-1 and -2 possess four cysteine rich repeats, which are 
responsible for ligand binding (e.g. TNFα, lymphotoxin α) [139, 140].  
TNFR-1 contains a so called death domain (DD) at its cytosolic end [141, 142]. The DD has 
no enzymatic activity at its own, but acts as docking platform for adaptor proteins. In contrast, 
TNFR-2 directly interacts with TNF receptor associated factors (TRAFs). TNF induced 
TNFR-1 mediated signal transduction is depicted in Fig. 7. 
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Under physiological conditions, the DD of the TNFR1 homotrimer is masked by the silencer 
of death domain (SODD), preventing unintentional activation of the signalling cascade. After 
ligand binding, the receptor complex undergoes conformational changes, leading to the 
release of SODD and recruitment of DD-containing adaptor proteins. The first adaptor protein 
recruited is TNFR1-associated protein containing DD (TRADD) via DD-DD interaction [143, 
144]. TRADD acts as assembly platform for further adaptor proteins. Depending on the 
recruited proteins, two different complexes are formed, complex I or II, initiating different 
signalling cascades.  
Complex I (pro-inflammatory, anti-apoptotic) consists of the receptor interacting protein 
(RIP), the cellular inhibitor of apoptotic protein (cIAP) and the TNFR-1-associated factor 2 
and/or 5 (TRAF 2/5) [143]. The formation of the complex I induces the anti-apoptotic MAP 
kinases p38 and JNK [145.147] and the pro-inflammatory response by activation of the 
NFκB-pathway [148, 149].  
The formation of complex II leads to opposing reactions, such as apoptosis. In this case, the 
Fas associated protein with DD (FADD) is recruited by TRADD. FADD recruits the inactive 
procaspase-8 and/or -10 which undergoes activation by autocatalytic cleavage. The activated 
initiator caspases cleave the inactive proform of the executioner caspase-3. The activated 
caspase-3 cleaves cellular structure proteins as well as DNA [150-154].  
1.2.6 NFκB signalling 
NFκB is one of the most important signalling proteins in the centre of inflammatory processes 
[155]. Different inflammatory signalling cascades (e.g. TLR-signalling, TNFR-signalling, as 
shown above) are integrated at NFκB and induce and/or modulate the expression of 
inflammation related genes [156]. Additionally, recent data suggest an important role of 
NFκB signalling also in differentiation, cell survival and proliferation [157].  
Besides regulatory elements, the core components of the NFκB pathway are the inhibitor of 
κB kinase- (IKK-) complex, the inhibitor of NFκB (IκB) and the nuclear transcription factor 
kappa B (NFκB) [158]. The general process of NFκB activation starts with a stimulus-induced 
activation of IKK (e.g. by LPS, TNF). This leads to phosphorylation, ubiquitination and 
proteasomal degradation of IκB. The degradation of IκB releases NFκB which translocates 
into the nucleus and binds to its target genes and induces gene transcription. The process is 
summarised in Fig. 8. 
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Fig. 8 Schematic overview of NFB activation. 
 
Up to now, five NFκB-protein family members are known, p50, p52, p65 (RelA), c-Rel and 
RelB . All of them contain an N-terminal Rel homology domain (RHD), necessary for hetero- 
and homodimerisation of NFκB family members as well as for DNA-binding at so called κB-
binding sites within the promoter region of target genes. Only p65, c-Rel and RelB contain a 
transcription activation domain (TAD). The TAD is responsible for, nomen est omen, 
activation of target gene transcription [160]. In the unstimulated state, two proteins of the 
NFκB family (mostly p65/p50) form hetero-dimers that hetero-oligomerise with a member of 
the IκB family. The binding of an IκB protein to the NFκB dimer prevents the nuclear 
translocation of the NFκB by masking its nuclear translocation sequence. Three classical IκB 
family members are known: IκB, IκBβ and IκB (acting in the canonical NFκB pathway) 
[161], as well as their precursor proteins p100 and p105, which are involved in alternative 
NFκB signalling [162, 163]. Additionally, three atypical IκB proteins belong to the IκB 
family: IκB, IκBNS and Bcl-3. Their mode of activation and functions differ from the typical 
IκB family members [164-166].  
After activation of the NFκB pathway, IκB is phosphorylated by activated IKK, gets 
ubiquitinated and is degraded in the 26S proteasome, thereby releasing the NFκB dimer for 
nuclear translocation and target gene transcription [167]. The IKK-complex is a trimer 
consisting of two homologue kinases IKK and IKKβ and a regulatory subunit, the NFκB 
essential modulator (NEMO/IKK). Up to now, the complex mechanism of IKK activation is 
not completely resolved. In TLR signalling the information is mediated by MyD88, the 
adaptor proteins IRAK1/4 and TRAF6 leading to IKK activation via TAK1 and/or AP-1 [168, 
169]. But how this activation is mediated in detail is still unknown. Different possible 
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mechanisms are discussed, like autophosphorylation, ubiquitination or an unknown upstream 
IKK-kinase. One explanation could be that TRAF6 acts as E3 ligase and cooperates with the 
E2 ligase Ubc13/Uev1A [170] or K63 [171]. But it is not yet possible to determine, if the 
ubiquitination of IKK takes place before or after IKK activation [172]. The activation of IKK 
during TNFR signalling is as mysterious as in TLR signalling. But it has been shown that 
TRAF2 and 5 are likely to be redundant in their functions. In knock out experiments deletion 
of one of both proteins did not lead to impaired NFκB activation only double knock out of 
both proteins affected TNF signalling [173-175]. As mentioned above, activation of IKK by 
TNFR-1 signalling induces the expression of anti-apoptotic genes (e.g. cIAP, BclXL).  
In addition to its central role in inflammatory response regulation, NFκB is also involved 
during the resolution of inflammation. It has been shown, that inflammatory gene 
transcription is inhibited after repeated or elongated LPS exposure [176]. Responsible for the 
resolution of inflammation are the NFκB family members Bcl-3 and p50. They also induce 
the transcription of the anti-inflammatory cytokine IL-10 and have a negative effect of IFN 
expression in natural killer cells [177]. The role of the NFκB signalling pathway in anti-
inflammatory processes is further supported by the finding that IKK-KO M show 
increased release of pro-inflammatory chemo- and cytokines [178, 179]. 
1.2.7 Influence of inflammatory stimuli on the peroxisomal compartment 
Up to now, little is known about the effect of inflammatory stimuli on the peroxisomal 
compartment of M. There are reports which link impaired peroxisomal function to increased 
inflammatory response in different organs. Data from brains of patients suffering from 
adrenoleukodystrophy (X-ALD) show a higher inflammatory state [180]. Interestingly, blood 
monocytes from patients suffering from X-ALD show an elevated level of TNF release 
[181]. Furthermore brains of twitcher mice, a mouse model for Krabs disease, show increased 
TNF expression, leading to impaired peroxisome function [182]. In experimental 
encephalomyelitis, impaired peroxisomal function has been observed [183]. All these reports 
have in common, that inflammatory processess mediated by TNF impairs peroxisomal 
function in the brain. Especially ROS degradation and myelin production were affected, 
leading to severe neuronal defects. It is suggested, that reduced PPAR expression during 
inflammation is a reason for the impaired peroxisome function in brain tissue. 
In mouse liver, Hall et al. reported, that the inflammatory state depends on the expression 
level of peroxisomal β-oxidation proteins [184]. Taken into account the results of Khan et al. 
[185] who reported, that Kupffer cells are involved in endotoxin induced changes in the 
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peroxisomal compartment of hepatocytes. According to this, Contreras et al. gives further 
insights of peroxisomes in Kupffer cells during inflammatory processes in the liver [186]. It 
seems evident, that peroxisomes play a decisive role in inflammatory response modulation in 
liver.  
However, there are few reports which directly link peroxisomes in M to inflammation, e.g.  
Lanuzzel et al., who reported an increased TNF release from blood monocytes in X-ALD 
patients [181] and the work of Karnati et al. who described the role of peroxisomes in mouse 
and human lung M.  
Taken together, it is obvious, that up to now knowledge about peroxisomes in M is rare and 
we have just scratched at the surface on the role of peroxisomes in MΦ during inflammatory 
processes. 
 
1.3 Atherosclerosis 
Atherosclerosis (AS) and related cardiovascular diseases are one of the most important causes 
of death in western society [187]. Additionally, treatment of these diseases and their 
complications result in the highest costs in the public health system [188]. There are several 
risk factors, increasing the threat of cardiovascular diseases. The most important factors are 
age, male sex, obesity, smoking, hypertension, “Diabetes mellitus” and high serum 
cholesterol concentrations [189, 190]. 
AS is characterised by a local accumulation of (oxidized) lipids (lipoproteins, free fatty acids 
and cholesterol) and leukocytes in the large and medium large arteries, leading to chronic 
inflammation and subsequently to a thickening of the vessel wall. These areas of leukocyte 
aggregation and lipid deposition are called “plaques”. Plaques tend to be destabilised by 
leukocytic action and rupture, leading to severe pathologic consequences such as cerebral 
ischemia or myocardial infarction (the progress of AS is reviewed in detail in [189-191]). 
The initial event of AS is the appearance of “fatty streaks” beneath the endothelium of large 
and medium large arteries. The most important event in the formation of “fatty streaks” is the 
entrance of low density lipoproteins (LDL) into the intima, which lies beneath the 
endothelium of the vessel wall and subsequently recruiting monocytes and T-cells by factors 
released from endothelial cells. While LDL is in the blood stream, as part of the fatty acid 
(FA) and cholesterol delivery system, it is not affected by oxidative modifications, but after 
accessing the intima its components are susceptible to enzymatic and non-enzymatic 
modification. This ongoing reactions lead to the oxidative modification of the lipid and 
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protein moieties of the LDL, called oxidized LDL (oxLDL). Endothelial cells express cell-
adhesion molecules (V-CAM, I-CAM, selectins) and secrete MΦ attractants (MCSF, MCP-1) 
as a response to the oxLDL in the intima, leading to MΦ and T-cells the recruitment [189-
191]. The recruited MΦ recognise the oxLDL not via their LDL-receptors but via scavenger 
receptors (CD36, SR-A) and TLR-4. The uptake of oxLDL is not regulated .This uncontrolled 
uptake and storage of oxLDL by the MΦ leads to the formation of foam cells [189, 192].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Schematic overview of the initiating events of a atherosclerotic lesion.  
From Glass and Witztum 2001 [189].  
LDL in the intima is oxidatively modified. The oxLDL induces the expression of adhesion molecules in the 
endothelial cells, which attract free floating blood monocytes to attach. Monocytes migrate into the intima 
and differentiate into macrophages. Foam cell formation is driven by unregulated oxLDL uptake via 
scavenger receptors and storage.  
 
A further step in plaque development is the immigration of smooth muscle cells (SMC) from 
the media across the lamina interna elastica into the intima of the vessel wall. The SMC 
proliferate and synthesize extracellular matrix proteins (e.g. Fibrin, Collagen, Proteoglycane) 
leading to the formation of a fibrous cap above the accumulating foam cells. Foam cells die 
by apoptotsis or necrosis due to their unregulated uptake of oxLDL and possibly due to free 
cholesterol in the plaque. This leads to the formation of a “necrotic core” within the plaque, 
which consists of cell debris and extracellular lipids. This stage of development is 
characterised by the constitution of the fibrous cap and MΦ and T-cells interaction leading to 
the establishment of a chronic inflammatory state. According to the inflammatory state of the 
intima and the above lying endothelium, further leukocytes are recruited to the plaque, 
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contributing to an ongoing growth of the plaque. In early stages this plaque growth is 
compensated by remodelling of the vessel wall. At later stages, the plaque growth into the 
vessel lumen, disturbing the blood flow and oxygen supply [189-191]. In an advanced plaque, 
MΦ express tissue factors inhibiting the production of matrix proteins by SMC and release 
matrix metallo proteases (MMP) degrading the existing extracellular matrix. Consequently, 
the fibrous cap gets destabilised. If the cap collapses, tissue factors are exposed to blood 
components, initiating the coagulation cascade with the recruitment of platelets and thrombus 
formation. The following pathologic events include cerebral apoplexy or myocardial 
infarction, depending on the affected artery [189-191]. 
 
It is very likely, that peroxisomes play an important role in storing and degrading oxidized 
elements of the phagocyted (ox)LDL particles given the broad substrate range of the 
peroxisomal β-oxidation system. They might also have an influence on the extend of 
macrophage activation after oxLDL consumption. 
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2. Objectives of this study 
Macrophages play a central role in innate immunity by phagocytosis of pathogens and their 
role as antigen presenting cells in the adaptive immune system. Although it is known that 
macrophages contain peroxisomes, very little is known about the role and the function of 
peroxisomes in M during inflammatory processes.  
 
Main Objectives of the study were: 
 
 To establish methodical protocols for the study of peroxisomes in macrophages 
 To reveal the effects of pro-inflammatory stimuli on the peroxisomal compartment  
 To compare the effects of LPS or oxLDL treatment on the peroxisomal compartment 
of macrophages 
 To characterise the underlying signalling pathways involved in the regulation of 
peroxisomal genes after LPS stimulation 
 To reveal the consequences of peroxisomal dysfunction on the inflammatory response 
of macrophages by the example of cultivated murine Pex11 KO MΦ 
 
 
The results of this study provide reliable methods for peroxisome research in M as well as 
first insights into the role of peroxisomes in Mduring inflammatory processes. The gained 
knowledge provides a deeper understanding of intracellular processes in acute inflammation 
and the resolution of inflammation as well as the molecular pathogenesis of chronic 
inflammatory processes in peroxisomal disorders. Future studies will shed light on the 
influence of peroxisomes in chronic inflammatory processes such as neurodegenerative 
diseases or atherosclerosis.  
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3. Material and Methods 
3.1 Material 
3.1.1 Laboratory equipment 
All equipment used during this thesis is listed at Tab. 7 
Tab. 7: Laboratory equipment 
Instruments Company 
AGFA Horizon Ultra Colour Scanner AGFA Mortsel, Belgium 
Biocell A10 water system Milli Q-Millipore, Schwalbach, Germany 
Biofuge Fresco Heraeus, Hanau, Germany 
Biofuge Pico Heraeus, Hanau, Germany 
Mini-Protean 3 System, electrophoresis 
apparatus 
Bio-Rad, Heidelberg, Germany 
Dias, microplate reader Dynatech Laboratories, Alexandria, USA  
Dish washing machine Miele, Gütersloh, Germany 
Gel-Doc 2000, gel documentation system Bio-Rad, Heidelberg, Germany 
Hera cell 240 incubator Heraeus, Hanau, Germany 
Hera safe, clean bench Heraeus, Hanau, Germany 
Scotsman AF-100, ice machine Scotsman Ice Systems, Vernon Hills,USA 
iCycler, PCR machine Bio-Rad, Heidelberg, Germany 
Leica DMRD, fluorescence microscope Leica, Bensheim, Germany 
Leica DC 480 camera Leica, Bensheim, Germany 
Leica TCS SP2, confocal laser scanning 
microscope 
Leica, Heidelberg, Germany 
Microwave oven LG, Willich, Germany 
Mini-Protean 3 cell, gel chamber Bio-Rad, Heidelberg, Germany 
Multifuge 3 SR centrifuge Heraeus, Hanau, Germany 
pH meter IKA, Weilheim, Germany 
Pipettes (2.5 µl, 20 µl, 100µl, 1000 µl) Eppendorf, Hamburg, Germany 
Potter-Elvehjem homogenizer B.Braun, Melsungen, Germany 
Power supplies - 200, 300 and 3000 Xi Bio-Rad, Heidelberg, Germany 
Pressure/Vacuum Autoclave FVA/3 Fedegari, Albuzzano, Italy 
Sorvall Evolution RC centrifuge Kendro, NC, USA 
SmartspecTM 3000 spectrophotometer Bio-Rad, Heidelberg, Germany 
T25 basic homogenizer IKA, Staufen, Germany 
Trans-Blot SD, semidry transfer cell Bio-Rad, Heidelberg, Germany 
TRIO-thermoblock Biometra, Göttingen, Germany 
Ultra balance LA120 S Sartorius, Göttingen, Germany 
Ultra Turrax T25 basic homogenizer Junke & Kunkel, Staufen, Germany 
Vortex M10 VWR International, Darmstadt, Germany 
Water bath, shaker GFL 1083  GFL, Burgwedel, Germany 
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3.1.2 Kits 
All kits used in this thesis are listed in Tab. 8. 
Tab. 8 List of used kits 
Substance Company 
BD OptEIA, mouse TNF Elisa Set II BD Biosciences, Heidelberg, Germany 
Cytotoxicity Detection Kit
plus
 Roche, Grenzach-Wyhlen, Germany 
RNeasy® Mini Kit Qiagen, Hilden, Germany  
 
3.1.3 Chemicals 
All chemicals used in this thesis are summarised in Tab. 9. 
Tab. 9 List of chemicals 
Substance Company 
12-Tetra-decanoyl-phorbol-13-acetate (TPA) Sigma, Steinheim, Germany 
Acrylamide Roth, Karlsruhe, Germany 
Agarose LE Roche, Grenzach-Wyhlen, Germany 
Alcian Blue 8Gx Fluka, Neu-Ulm, Germany 
Alizarin Red S Fluka, Neu-Ulm, Germany 
Ammonium persulfate (APS) Roth, Karlsruhe, Germany 
Ascorbic acid Sigma, Steinheim, Germany 
Bradford reagent Sigma, Steinheim, Germany 
Bromophenol blue Riedel-de-Haën, Seelze, Germany 
Calcium chloride Merck, Darmstadt, Germany 
Citric acid Merck, Darmstadt, Germany 
Ethanol Riedel-de-Haën, Seelze, Germany 
Ethidium bromide Fluka, Neu-Ulm, Germany 
Ethylene diamine tetraacetic acid (EDTA) Fluka, Neu-Ulm, Germany 
Dimethyl sulfoxide (DMSO) Sigma, Steinheim, Germany 
Formvar 1595 E  Serva, Heidelberg, Germany 
Glutaraldehyde (GA) Serva, Heidelberg, Germany 
Glycine Roth, Karlsruhe, Germany 
Glycerol Sigma, Steinheim, Germany 
β-Glycerolphosphate Sigma, Steinheim, Germany 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) 
Roth, Karlsruhe, Germany 
Hydrogen peroxide (H2O2) Merck, Darmstadt, Germany 
L-Glutamate  Cambrex BioScience, MD, USA 
Lipopolysaccharide (LPS) Sigma, Steinheim, Germany 
β-Mercaptoethanol Sigma, Steinheim, Germany 
Milkpowder, fat free Roth, Karlsruhe, Germany 
3-[N-Morpholino]-propanesulfonic acid (MOPS) Serva, Heidelberg, Germany 
Mowiol 4-88 Polysciences, Eppelheim, Germany 
N-propyl-gallate Sigma, Steinheim, Germany 
Paraformaldehyde (PFA) Sigma, Steinheim, Germany 
Penicillin/Streptomycin  PAN Biotech, Aidenbach, Germany 
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Phenylmethanesulfonyl fluoride (PMSF) Serva, Heidelberg, Germany 
1,4 Piperazine bis 2-ethanosulfonic acid (PIPES) Sigma, Steinheim, Germany 
Ponceau S Serva, Heidelberg, Germany 
Potassium hexacyanoferrate Merck, Darmstadt, Germany 
Potassium hydrogen phosphate Sigma, Steinheim, Germany 
Potassium chloride Sigma, Steinheim, Germany 
Rotiphorese Gel 30 Roth, Karlsruhe, Germany 
Protease Inhibitor Mix M Serva, Heidelberg, Germany 
RNaseZap Sigma, Steinheim, Germany 
Sodium carbonate Merck, Darmstadt, Germany 
Sodium chloride Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate Merck, Darmstadt, Germany 
Sodium hydrogen phosphate Sigma, Steinheim, Germany 
Sodium hydroxide Merck, Darmstadt, Germany 
Sodium dodecyl sulfate (SDS) Sigma, Steinheim, Germany 
saccharose Merck, Darmstadt, Germany 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe, Germany 
Tris hydroxymethyl aminomethane (TRIS) Merck, Darmstadt, Germany 
Triton X-100 Sigma, Steinheim, Germany 
Trypan blue Sigma, Steinheim, Germany 
Tween20 Fluka, Steinheim, Germany 
 
3.1.4 Buffers and solutions 
All buffers and solutions used for immunofluorescence microscopy are listed in Tab. 10. 
Tab. 10 Buffers and solutions for immunofluorescence microscopy 
Solution/Buffer Components 
10x PBS  1.5 M NaCl, 131 mM K2HPO4 , 50 mM KH2PO4, pH 7.4 
Blocking buffer  4.0 % PBSA + 0.05 % Tween20 
Dilution buffer 1.0 % PBSA + 0.05 % Tween20 
Anti-fading agent 2.5 % N-propyl-gallate in PBS + 50.0 % glycerol 
Mounting medium  25.0 % propylgalat in Mowiol 4-88 
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All buffers, solutions and general materials used for Western Blot analysis are listed in Tab. 
11. 
Tab. 11 Buffers, solutions and general materials for Western blot analysis 
Solution/Buffer Components 
Homogenisation Buffer (HB) 
250 mM saccharose, 5.0 mM MOPS 
Before use, add 0.1 % ethanol, 1.0 mM EDTA, 0.2 mM DTT,  
1.0 mM  6 mM aminocapron acid,  
2.0 protease inhibitor mix (according to the manual) 
Buffer A (resolving gel ) 1.5 M Tris-HCL, pH 8.8 + 0.4 % SDS 
Buffer B (stacking gel) 0.5 M Tris-HCL, pH 6.8 + 0.4 % SDS 
12 % separation gel 
8.0 ml 30 % acrylamide + 10.0 ml buffer A  
+ 2.0 ml ddH2O + 15.0 μl TEMED + 130.0 μl 10 % APS 
Stacking gel 
1.25 ml 30 % acrylamide + 5.0 ml buffer B  
+ 5.0 ml ddH2O + 15.0 μl TEMED + 130.0 μl 10 % APS 
10x TBS 100 mM Tris + 150 mM NaCl in 1000 ml of ddH2O, adjust to pH 8.0 
1x TBST, Washing buffer 10 mM Tris/HCl, 15 mM NaCl, 0.05 % Tween20 
SDS Sample buffer, 
Laemmli buffer 
0.5 M Tris-HCL pH 6.8, 10 % SDS 
3.55 ml ddH2O + 1.25 ml 0.5 M Tris-HCl pH 6.8  
+ 2.5 ml Gycerol +2.0 ml 10 % (W/V) SDS  
+ a spatula tip of Bromphenol blue  
before use add 5.0 % -Mercaptoethanol  
5.0 % Blocking buffer 5.0 % fat free milk in TBST 
10.0 % Blocking buffer 10.0 % fat free milk in TBST 
5x Elektrophoresis buffer 250 mM Tris + 2 M glycin + 1.0 % SDS 
BioMax MR-films Kodak, Stuttgart, Germany 
Dental READYMATIC Developer Kodak, Stuttgart, Germany 
Dental READYMATIC Fixer Kodak, Stuttgart, Germany 
Immobilon ® P 
PVDF membranes 
Millipore, Schwalbach, Germany 
Immun Star™-AP substrate Bio-Rad, Heidelberg, Germany 
NuPage transfer buffer Invitrogen, Karlsruhe ,Germany 
Precesion StrepTactin 
-AP conjugate 
Bio-Rad, Heidelberg, Germany 
Precision Plus™ protein 
standards, dual color 
Bio-Rad, Heidelberg, Germany 
Precision Plus™ protein 
standards, unstained 
Bio-Rad, Heidelberg, Germany 
Protean ® XL size filter paper Bio-Rad, Heidelberg, Germany 
 
All buffers and solutions used for molecular biology are listed in Tab. 12. 
Tab. 12 Buffers and Solutions for molecular biology 
Solution/Buffer Components 
10x TAE buffer 
40 mM Tris base + 20 mM acetic acid  
+ 1 mM EDTA, pH 7.6 
RNA-loading dye 
16.0 μl saturated aqueous bromophenol blue  
+ 80 μl 500 mM EDTA pH 8.0  
+ 720 μl 37 % formaldehyde 
+ 4.0 ml 10x gel buffer  
fill up to 10 ml with ddH20 
10x RNA transfer buffer 
200 mM MOPS + 50 mM sodium acetate 
+ 10 mM EDTA, pH 7.0 
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3.1.5 Cell culture material and media  
All media and materials used for cell culture are listed in Tab. 13. 
Tab. 13: Cell culture materials 
General materials and culture media Company 
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) 
Sigma-Aldrich, Munich, Germany 
Accutase PAA, Pasching, Austria 
Cell culture dishes (35mm, 60mm, 100mm) Sarstedt, Nürnbrecht, Germany 
Cover slips Menzel-Gläser, Braunschweig, Germany 
Dulbecco's Modified Eagle's Medium (DMEM) PAA, Pasching, Austria 
Fetal calf serum (FCS) PAA, Pasching, Austria 
Filter tips and canules Braun, Melsungen, Germany 
Molecular weight markers (DNA, RNA) Fermentas, St.Leon-Rot, Germany 
Multi-well cell culture plates (6-, 12-, 24- wells) Sarstedt, Nürnbrecht, Germany 
Roswell Park Memorial Institute medium (RPMI) -1640 PAA, Pasching, Austria 
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3.1.6 PCR primer and reagents 
The following oligo-nucleotides were synthesised by Operon, Cologne, Germany and were 
used as primers for RT-PCR. 
Tab. 14: Primer pairs for RT-PCR 
Gene target 
Sense primer (5´-3´) 
PCR Produkt [bp] 
Annealing 
Temp. [°C] Antisense primer (5´-3´) 
28s rRNA 
CCTTCGATGTCGGCTCTTCCTAT 
254 65 
GGCGTTCAGTCATAATCCCACAG 
Pro-inflammatory response 
COX2 
GCAAATCCTTGCTGTTCC 
364 60 
GGAGGAAGGGCCCTGGTG 
iNOS 
CTATCTTGAAGCCCCGCTACTA 
475 60 
ATGTCCTGAACGTAGACCTTGG 
TNF 
TGTCTACTGAACTTCGGGGTGA 
378 62 
GGCAGAGAGGAGGTTGACTTTC 
HO-1 
GCACTATGTAAAGCGTCTCCACGAG 
610 64 
CCAGGCAAGATTCTCCCTTACAGAG 
peroxisomal fission 
PEX11 
TCAGCTGCTGTGTTCTCAGTCCTT 
420 64 
GTACTTAGGAGGGTCCCGAGAGGA 
DLP-1 
CGGTGGTGCT AGG ATT TGT T 
368 60 
GCA CCA TTT CAT TT GTC ACG 
H2O2 degradation 
Catalase 
GGAGAGGAAACGCCTGTGTGA 
103 60 
GTCAGGGTGGACGTCAGTGAAA 
fatty acid degradation/transport 
Thiolase 
TCAGGTGAGTGATGGAGCAG 
241 60 
CACACAGTAGACGGCCTGAC 
ABCD3 
CTGGGCGTGAAATGACTAGATTGG 
523 56 
AGCTGCACATTGTCCAAGTACTCC 
peroxisomal protein import 
PEX13 
GACCACGTAGTTGCAAGAGCAGAGT 
717 64 
CTGAGGCAGCTTGTGTGTTCTACTG 
PEX14 
CACTGGCCTCTGTCCAAGAGCTA 
298 65 
CTGACAGGGGAGATGTCACTGCT 
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All reagents used for quantitative or reverse transcriptase PCR are listed in Tab. 15. 
 
Tab. 15: RT-PCR reagents 
PCR reagents Company 
10x DNase-I reaction buffer Invitrogen, Karlsruhe, Germany 
10x PCR buffer Invitrogen, Karlsruhe, Germany 
5x First strand buffer Invitrogen, Karlsruhe, Germany 
DNase-I, amplification grade, 1 U/u Invitrogen, Karlsruhe, Germany 
dNTP mix (10mM each) Invitrogen, Karlsruhe, Germany 
DTT 0.1 M Invitrogen, Karlsruhe, Germany 
EDTA 25 mM Invitrogen, Karlsruhe, Germany 
Low DNA mass ladder Invitrogen, Karlsruhe, Germany 
Oligo (dT) primer Invitrogen, Karlsruhe, Germany 
RNase OUT (40 units/µl)  Invitrogen, Karlsruhe, Germany 
SuperScript II reverse transcriptase Invitrogen, Karlsruhe, Germany 
Taq DNA polymerase  Invitrogen, Karlsruhe, Germany  
 
3.1.7 Primer pairs for quantitative PCR 
The primer pairs used for qPCR are listed in Tab. 16 
Tab. 16 List of qPCR primer pairs  
Gene Target 
Sense primer (5´-3´) 
PCR Produkt [bp] 
Annealing 
Temp. [°C] Antisense primer (5´-3´) 
Pro-inflammatory response 
COX2 
cctcctggaacatggactca 
173 61 
agaagcgtttgcggtactca 
iNOS 
ccaagccctcacctacttcc 
156 61 
gggttgttgctgaacttcca 
TNF 
cctgtagcccacgtcgtag 
148 61 
gggagtagacaaggtacaaccc 
Housekeeping gene 
Gnb2l 
actcccacttcgttagtgagt 
100 61 
cccttgtgagatcccagag 
Rpl37 
gctaaacgcaccaagaaggtc 
197 61 
gccactgttttcatgcaggaa 
Hprt 
agtcccagcgtcgtgattag 
88 61 
tttccaaatcctcggcataatga 
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3.1.8 Software 
For image processing and evaluation, we used the following software: 
 imageJ: Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, 
Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2009. 
 AdobePhotoshop CS2 Version 9.0 
For statistical analysis of the data, we used Microsoft® Excel 2003, SP3 
 
3.1.8 Antibodies and inhibitors 
All primary antibodies used during this thesis are listed in Tab. 17. 
Tab. 17: Primary antibodies for Western blot analysis and immunofluorescence staining 
Primary antibodies host dilution source 
WB IF 
MΦ activation marker 
CD68, mouse, monoclonal rat 1:1,000 - 
AbD Serotec, Düsseldorf, 
Germany 
H2O2 degradation 
Catalase, mouse, polyclonal rabbit 1:30,000 1:5,000 D. I. Crane, Brisbane, AUS 
peroxisomal protein import 
Pex13p, mouse, polyclonal rabbit 1:15,000 - D. I. Crane, Brisbane, AUS 
Pex14p, mouse, polyclonal rabbit 1:30,000 1:5,000 D. I. Crane, Brisbane, AUS 
peroxisomal fatty acid transport/degradation 
Peroxisomal 3-keto-Acyl CoA-
Thiolase (thiolase),  
mouse, polyclonal 
rabbit 1:15,000 - 
P. P. van Veldhoven, 
Leuven, Belgium 
ABCD3, mouse polyclonal rabbit 1:2,000 - A. Völkl, Heidelberg, Germany 
autophagosomal marker 
LC-3  mouse 1:1,000 1:500 Biozol, Eching, Germany 
apoptose marker 
Cleaved Caspase-3,  
Mouse, polyclonal 
 1:1,000 - Cell Signaling, Danvers, USA 
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All secondary antibodies used during this thesis are listed in Tab. 18 and Tab. 19. 
Tab. 18: Secondary antibodies for Western blot analysis and immunofluorescence staining 
secondary antibodies species dilution source 
WB IF 
-rabbit IgG,  
alkaline phosphatase bound 
goat 1:30,000 - 
Sigma-Aldrich, Hamburg, 
Germany 
-mouse IgG,  
alkaline phosphatase bound 
goat 1:30,000 - 
Sigma-Aldrich, Hamburg, 
Germany 
-rat IgG, alkaline phosohatase bound goat 1:30,000 - 
Sigma-Aldrich, Hamburg, 
Germany 
-rabbit IgG, Alexa Fluor 488  donkey - 1:300 
Molecular Probes, 
Karlsruhe, Germany 
-mouse IgG, Alexa Fluor 633  donkey - 1:300 
Invitrogen, 
Karlsruhe, Germany 
 
Tab. 19: Counterstaining of nuclei for immunofluorescence 
dye dilution source 
DAPI, Hoechst 22358 1:300  
Toto-3 iodide 1:300 
Molecular Probes, 
Karlsruhe, Germany 
 
Inhibitors of inflammatory signalling pathways are listed in Tab. 20. 
Tab. 20 Inhibitors 
Inhibitor function company 
Celastrol Inhibits NFB signalling InvivoGen, Toulouse, France 
CLI-095 Prevents LPS binding to TLR-4 InvivoGen, Toulouse, France 
SPD-304 Prevents TNF-TNF-R interaction Sigma, Steinheim, Germany 
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3.2 Animals 
3.2.1 Mice 
Specified pathogen free (SPF) C57Bl/6J wild type mice were purchased for experimental 
purposes from Charles River Laboratories (Sulzfeld, Germany). They were kept on a normal 
laboratory diet and water ad libitum and housed in cages under standardised environmental 
conditions (12 hours light/dark cycle, 23°C ± 1°C and 55 % ± 1 % relative humidity). The 
mice were transported to our institute two days prior to the experiments.  
PEX11 KO mice were kept at the central animal facility (University Gießen) until M 
isolation. Animals were delivered the day before isolation and kept overnight under 
standardized environmental conditions (12 hours light/dark cycle, 23°C ± 1°C and 55 % 
 ± 1 % relative humidity). 
3.3 Primary cells and cell lines 
3.3 1 RAW 264.7 
This mouse macrophage cell line was established from an Abelson leukaemia virus [193]. The 
cell line was originally bought at ATCC and was a kind gift of our collaborator Dr. S. 
Immenschuh (Institut für Transfusionsmedizin, Medizinische Hochschule Hannover). 
3.3.2 Primary mouse alveolar macrophages 
These cells were freshly isolated from C57BL/6J mice by alveolar lavage as described by 
Zhang et al. [194]. After cervical dislocation of the mice, the fur at the cervical region was 
removed, the skin was cut open and the trachea was exposed. Thereafter, a canula with an 
attached 1.0 ml syringe was inserted into the trachea and 0.5 ml of prewarmed PBS/0.5 mM 
EDTA was instilled into the trachea, withdrawn and the lavage was collected in a 15 ml 
falcon tube. The instillation and lavage steps were repeated 10 times and the collected lavage 
was centrifuged for 10 min at 400 g. Cells were counted with a Neubauer counting chamber. 
A cell number of 5x10
5
 per mouse was yielded. For further experiments, 1x10
5
 cells/well 
were plated in RPMI-1640/5 % FCS. After 4 h the medium and not attached cells were 
removed to get pure macrophage cultures and replaced with fresh medium, according to 
Zhang et al. [194].  
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3.3.3 Primary mouse peritoneal macrophages 
Cells were freshly isolated from C57BL/6J mice by peritoneal lavage, as described by Ray et 
al. [195]. After isolation, the number of cells was determined using a Neubauer counting 
chamber according to the manual. A regular isolation yielded 1.5x10
6 
cells per mouse. The 
cells were plated for experiments with a density of 2.0x10
5
 cells/well. 
 
3.4 Methods  
3.4.1 Cell culture 
RAW 264.7 murine M were cultivated in high glucose (4.5 g/l) DMEM (PAA) which 
contained 10 % heat inactivated FCS and 1.0 % penicilin/streptamycin-mix.  
Isolated alveolar M cells were cultivated in RPMI-1640 (PAA) + 5 % heat inactivated FCS 
and 1 % penicilin/streptamycin-mix.  
Isolated peritoneal M were cultivated in high glucose (4.5 g/l) DMEM, containing 10 % 
heat inactivated FCS and 1 % penicillin/streptomycin-mix. 
All cells types were incubated at 37°C, 5.0 % CO2 and 95.0 % humidity. All cell culture 
procedures were done under sterile conditions. All solutions were preheated at 37°C before 
use, if not specified elsewhere. 
3.4.2 Methylthiazole tetrazolium (MTT) assay 
Methylthiazole tetrazolium (MTT) is a yellowish powder. In living cells, mitochondrial 
dehydrogenases convert MTT into a dark blue coloured water-insoluble MTT-formazan 
product.  
Before use, MTT was dissolved in DMSO for a 5.0 mg/ml stock solution. For cell viability 
determination, 20 µl of the stock solution were added into the culture medium of each sample, 
after the indicated treatment time and incubated for another 20 min at 37°C. Thereafter, the 
medium was discarded and the blue insoluble MTT-formazan was dissolved in 100 µl DMSO. 
The extinction of each sample was measured at 570 nm with a Dias microplate reader 
(Dynatech Laboratories). Each sample was measured in triplicates and each experiment was 
repeated at least three times. Changes in extinction were normalized against the untreated 
control. To calculate the percentage of cell viability, the following formulawas used: 
A570 (treated cell)/A570 (non-treated cells) x 100. 
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3.4.3 Cytotoxicity assay 
To quantify cytotoxic effects, the Cytotoxicity detection Kit
plus 
(Roche) was used. This 
colourimetric test is based on the release of lactat dehydrogenase from damaged cells into cell 
culture medium. Cytotoxicity quantification was performed according to the manufacturer’s 
protocol. Absorbance was detected at a wavelength of 490 nm. 
3.4.4 Enzyme-linked Immunosorbent assay (ELISA) 
TNF levels were measured in the supernatant of cultured cells by using the ELISA BD 
OptEIA mouse TNF Elisa set (BD Biosciences) according to the manufacturer’s protocol. 
The absorbance was detected at 450 nm and a reference wavelength at 570 nm 
 
3.4.5 Western blot analysis 
Cell harvest 
The medium was withdrawn and the cells were washed once with PBS. Thereafter, cells were 
washed once with cold EDTA (0.5 M)/PBS solution followed by incubation with Accutase 
(PAA) at 37°C, 5 % CO2 for 8-10 min. Cells were collected with 5 ml PBS and centrifuged at 
900 rpm, 5 min. at RT. The supernatant was discarded and the pellet was resuspended in 1 ml 
PBS. After a second centrifugation at 4000 rpm, 5 min. RT, the supernatant was discarded 
and the cell pellet was frozen for further processing at -80 °C. 
Cell homogenisation and subcellular fractionation by differential centrifugation 
Homogenisation of RAW264.7 cells was performed by cell membrane disruption, using a 
Potter S homogenator (B Braun). Thawed Cells were resuspended in 100 µl of 
homogenisation buffer (HB), 0.25 M sucrose and 5 mM MOPS, pH 7.4. For 10 ml, 1.0 mM 
EDTA, 0.1 % ethanol, 0.2 mM DTT, 1.0 mM aminocaproic acid and 100 µl Protease Inhibitor 
Mix M (Serva) were added before use. The cells were homogenised for 180 s at 1000 rpm. 
Complete homogenisation was controlled by trypan blue staining of the cell sample and 
visualised by light microscopy. 
The homogenate was centrifuged at 100 g, 15 min at +4.0°C using a Sorvall Evolution 
centrifuge (Sorvall). The supernatant (U1) was withdrawn and collected in a 500 µl 
Eppendorftube (Eppendorf). The pellet was resuspended in 100 µl HB and homogenised 180 s 
at 1,000 rpm. This homogenate was centrifuged 15 min at 100 g. The supernatant (U2) was 
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withdrawn and mixed with U1. Forty µl of U1+U2 was frozen in liquid nitrogen. The pellet 
was resuspended in 40 µl HB and frozen in liquid nitrogen. 
Supernatant U1+U2 was centrifuged at 1,950 g, 15 min. if not indicated otherwise. The 
supernatant (U3) was withdrawn and collected in a 500 µl Eppendorf tube. The pellet was 
resuspended in 100 µl HB and centrifuged at 1,950 g, 15 min at +4.0 °C. The supernatant 
(U4) was withdrawn and mixed with U3. Forty µl of U3+4 was frozen in liquid nitrogen. The 
pellet was resuspended in 40 µl HB and frozen in liquid nitrogen. 
Supernatant U3+4 was centrifuged at 23,500 g, 15 min. The supernatant (U5) was withdrawn 
and collected in a 500 µl Eppendorf tube. The pellet was resuspended in 100 µl HB and 
centrifuged at 23,500 g, 15 min. The supernatant (U6) was withdrawn and mixed with U5. 
Forty µl of U5+6 were frozen in liquid nitrogen. The pellet was resuspended in 40 µl HB and 
frozen in liquid nitrogen. This pellet contains mainly peroxisomes, as well as light 
mitochondria, lysosomes and microsomes. For further western blot analysis of peroxiomal 
proteins, this fraction was used. 
All solutions and supernatants were kept on ice during homogenisation and peroxisome 
enrichment. All centrifugation steps were performed at +4 °C. For long-time storage, the 
samples were stored at -80 °C. 
Protein determination according to Bradford 
According to Bradford et al. [196], BSA was used as standard for protein determination in 
increasing concentrations (1.0 µg/ml, 2.5 µg/ml, 5.0 µg/ml, 10.0 µg/ml, 15.0 µg/ml and 25.0 
µg/ml). The HB alone was used as blank. Before determination, 1.0 µl of the sample was 
diluted in 124 µl ddH2O and mixed with 125 µl Bradford reagent. For protein measurement, 
the mixed solution was incubated 10 min at RT. The protein concentration was determined 
using the Smartspec™ 3000 spectrophotometer (BioRad) 
Gel preparation 
For protein resolving, a 12 % SDS-Page Gel was prepared using the Mini-PROTEAN 3 Cell 
(Bio-Rad), if not stated otherwise. Assembly of the gel chambers was according to the 
manual. After assembling, the chamber was filled with 70 % ethanol to remove all 
contaminations and check for sealing, the ethanol was discarded afterwards. The resolving gel 
was prepared according to the protocol (see Tab. 11) and filled into the chamber. To create an 
even surface, the resolving gel was overlaid with 70 % ethanol. The stacking gel was prepared 
during the polymerisation of the resolving gel, according to the protocol (see Tab. 11). 
Immediately after addition of the stacking gel the spacer were placed. 
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Sample preparation 
After protein determination, equal amounts of protein from each sample (7-30 µg) were 
mixed with 1x SDS sample buffer (Laemmli buffer). For protein denaturation, samples were 
heated 8 min at 95 °C, quickly chilled on ice and spinned down.  
Separation of proteins 
The prepared protein samples were filled each into one well of the gel chamber. The Precision 
Plus™ protein standards, dual colour (BioRad) and Precision Plus™ protein standards, 
unstained (BioRad) were mixed and used separately to determine protein size. The passage of 
the protein samples through the gel was done under a constant voltage of 200 V for 1 h. 
Protein transfer 
Before use, the Protean® filter paper (BioRad) was equilibrated in NuPAGE transfer buffer 
(Invitrogen). The used PVDF-membrane had to be wetted in 70 % ethanol and equilibrated in 
transfer buffer before use. One sheet of the equilibrated filter was placed in the Trans-Blot 
SD, semidry transfer cell (Bio-Rad). Then the wetted PVDF-membrane was placed on top of 
the filter paper (avoiding bubbles, rough side face up). The resolving gel was cut off from the 
stacking gel and placed upon the PVDF-membrane. A second filter paper was placed on top. 
Settings were C=constant at 1.8 mA/cm² for 1 h at RT. 
Protein detection 
Unspecific bindings were blocked by incubating the PVDF-membrane in 10 % milk/TBST for 
1 h at RT. Protein specific primary antibodies were diluted in 5 % milk/TBST and incubated 
overnight (O/N) at +4 °C. Thereafter, membranes were washed 3x15 min in TBST at RT on a 
shaker. The membrane was incubated at RT for 1 h with a secondary antibody (1:30,000 in 
TBST). During this time the secondary antibody, conjugated with alkaline phosphatase, binds 
to the primary antibody. After another 4x10 min washing in TBST at RT on shaker, the 
membrane was incubated with Immun Star™ AP substrate (BioRad) for 2 min at RT. The 
chemoluminescence was detected by BioMax MR (Kodak) with indicated exposure times. 
The x-ray film was developed in Dental READYMATIC developer (Kodak) for 2 min at RT, 
short wash in H2O and fixed in Dental READYMATIC fixer (Kodak) for 10 min at RT. Final 
washing in H2O at RT for 10 min. 
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3.4.6 RT-PCR 
Isolation of total mRNA 
Total mRNA of RAW264.7 as well as alveolar and peritoneal MΦ was isolated using the 
RNeasy Mini Kit (Qiagen). Cells were lysed in 350 µl RLT (lysis buffer) and homogenised by 
repeated suction and squirting (>15x) through a 19 gauge needle. RNA extraction was done 
according to the manufacturer’s protocol. The RNA was eluted with RNase free water and 
stored at -80°C. Quality and quantity control was performed by optical density measurement 
using the SmartspecTM 3000 spectrophotometer (BioRad). RNA integrity was determined by 
1 % agarose gel electrophoresis, visualising the 28s, 18s and 5s ribosomal RNA bands. 
Agarose gel electrophoresis  
RNA samples were mixed with 5x RNA loading buffer (4.0 µl sample RNA + 1.0 µl RNA 
loading buffer). To degenerate the sample RNA, the mixture was heated at 65 °C for 5 min. 
The samples were immediately chilled on ice afterwards and were loaded on a 1 % agarose 
gel. Separation was performed at 90 V for 30 min. 
Synthesis of cDNA 
To remove DNA contaminations from the total RNA preparation, a DNase-I digestion was 
performed. One microgram of RNA sample was added to the DNase-1 digestion mix. The 
mixture was incubated for 15 min at RT. The digestion process was stopped by adding 1.0 µl 
25 mM EDTA solution and subsequent incubation for 10 min at 65 °C. 
 
Tab. 21: DNase-1 digestion mix 
Reagent Quantity 
RNA sample 1.0 µl 
10x DNas-1 reaction buffer 1.0 µl 
DNase I, amplification grade, 1U/μl 1.0 µl 
RNase free water to 10.0 µl 
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cDNA preparation 
Total RNA was transcribed into cDNA according to the protocol below 
Tab. 22 Oligo(dT) primer mix 
Reagent Quantity 
Oligo(dT)12-18 (500 μg/ml) primer 1.0 μl 
RNA sample (1.0 μg)  ~ 4.0-8.0 μl 
dNTP mixture (10 mM each)  1.0 μl 
Sterile distilled water  to 12.0 μl 
 
For oligo(dT) primer annealing, the mixture was heated 5 min at 65°C and afterwards directly 
chilled on ice. To this mixture 4.0 µl 5x first strand buffer, 2.0 µl 0.1 M DTT and 1.0 µl 
RNaseOUT™ (40 U/μl) was added, mixed and incubated for 2 min at 42°C. To induce cDNA 
transcription, 1.0 μl of SuperScript™ II Reverse Transcriptase (200 U) was added and the 
whole mixture was incubated for 1 h at 42 °C. The reaction was stopped by heating it up to 
70°C for 15 min. After transcription, cDNA was stored for PCR at -20°C. All heating steps 
were performed in a TRIO-thermoblock (Biometra). 
RT-PCR reverse transcription polymerase chain reaction 
To analyse the abundance of specific mRNA within RAW264.7 or primary 
peritoneal/alveolar MΦ, we performed RT-PCR as a method to evaluate corresponding gene 
expression. 28s rRNA or Gnb2l were used as housekeeping genes for loading control. As 
negative control, we ran a “H2O” lane in parallel, were sample cDNA was replaced by water 
The RT-PCR master mix was prepared according to Tab. 23. 
 
Tab. 23: RT-PCR master mix 
Reagent Quantity 
cDNA sample (1.0 μg)  
0.7-1.2 μl 
(depending on cDNA concentration) 
10x PCR buffer  1.0 μl 
10 mM dNTPs  2.5 μl 
Forward primer (10.0 pmol/μl)  1.0 μl 
Reverse primer (10.0 pmol/μl)  1.0 μl 
Taq DNA polymerase (5 U/μl)  0.2 μl 
Nuclease free water  to 25.0 μl 
Total PCR volume 25.0 μl 
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The PCR reaction was performed in a BioRad iCycler, using the protocol in Tab. 24. The 
annealing temperature depends on the used primer pair (see Tab. 14) 
 
Tab. 24: RT-PCR cycling protocol 
repeats process Time [s] Temperature [°C] 
1x denaturation 360 94.0 
 
35x 
denaturation 30 94.0 
annealing 30 55.0-65.0 
elongation 30 72 
1x elongation 360 72 
 
Analysis of RT-PCR products 
After RT-PCR, samples were mixed with 2.0 µl 5x loading buffer, which contains the dye 
bromphenol blue. To analyse the RT-PCR products 10.0 µl of each sample were loaded on a  
2.0 % agarose gel (+ 0.5 % ethidium bromide). Separation was performed at 120 V for  
45 min. The PCR products were visualized by UV illumination of the gel using the Gel-Doc 
2000, gel documentation system (Bio-Rad). For semi quantitative interpretation of the data, 
intensity values of the samples were normalized against the values of 28s rRNA. 
 
3.4.7 Immunofluorescence 
RAW264.7 or primary mouse M were grown on 12 mm cover slips for immunofluorescence 
staining. Cells were fixed with 4.0 % PFA/PBS (pH 7.4) for 20 min at RT. For 
permeabilisation, cells were incubated in Triton X100 (0.01 % in PBS) for 10 min at RT. 
Aldehyde groups and other unspecific epitopes were blocked by incubating the cells in 0.1 % 
glycin, 5 min at RT to avoid unspecific staining. After each step, cells were washed with PBS 
15 min at RT. For primary antibody staining, cells were incubated with corresponding 
primary antibodies O/N at +4°C (for dilutions see Tab. 17). After incubation, the cells were 
washed 4x 10 min with PBS at RT. Primary antibody binding was visualised by incubating 
corresponding secondary antibody (see Tab. 18) for 2 h at RT. After incubation, the cells were 
washed 4x 10 min with PBS at RT. Nuclei were counterstained with TOTO-3 iodide and 
DAPI (for dilutions see Tab. 19) 10 min at RT. After incubation, cell were washed 1x with 
PBS 10 min at RT. Cover slips were mounted in a 3:1 mix of Mowiol 4-88 and N-
propylgalate to prevent bleaching of the dye. Cellular staining was analysed with a Leica 
DMRD fluorescence microscope (Leica). 
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3.4.8 Preparation of oxLDL 
For preparation of oxLDL, isolated LDL from human blood plasma was used. Before oxLDL 
preparation, a dialysis tube was activated by shortly boiling it in 5 mM EDTA in a 
microwave, followed by two times boiling in ddH2O. The tube was sealed afterwards on one 
side and a 1:1 dilution of LDL/PBS was inserted. The tube was sealed completely and 
incubated in PBS two times for 3 h at RT. The tube was transferred to 50 µM CuSO4 and 
incubated O/N at RT. The CuSO4 was neutralised with 50 µM EDTA for 1 h at RT. The 
oxidized LDL was sterile filtered and was stable for up to 14 days at +4°C. A small oxLDL 
sample was used for protein determination.  
An oxLDL sample was subjected to gel electrophoresis, using a 1.0 % agarose gel, with BSA 
as negative control, for oxidation control. The samples were stained with coomassi blue 1 h at 
RT after separation, 45 min at 80 V. Thereafter, the gel was discoloured in ddH2O overnight 
at RT. 
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4. Results 
 
At the beginning of this project, very little was known about the biology of peroxisomes in 
MΦ; except for morphological data from our group [1]. Nearly all published data in the 
literature on peroxisomal metabolism were based on investigations using liver [60, 61, 185, 
197-199] or kidney [56, 200] and for studies on peroxisomal biogenesis most research groups 
focused on fibroblasts or yeasts [201-205]. However, it was already known from previous 
work from our group and others, that peroxisomes are versatile organelles, changing their 
morphology and enzyme composition according to environmental and metabolic needs [206-
210]. Therefore, peroxisomes in macrophages might also adapt their peroxisomal 
compartment according to their activation state during inflammatory processes. However, no 
knowledge was available on peroxisome isolation in macrophages. Thus, all the techniques 
for isolating and staining of peroxisomes in macrophages had to be established within the 
experimental work of this thesis. 
 
In consequence, the Result section is subdivided into five parts: 
 
1. Transfer and establishing of protocols for M experiments. Isolation and cultivation of 
 primary and RAW264.7 M, followed by staining for and isolation of peroxisomes 
 from these cell types  
 
2. + 3. Effect of LPS or oxLDL on the inflammatory response and the peroxisomal  
  compartment of the murine RAW264.7 M cell line. 
 
4. + 5. Effect of LPS on the inflammatory response and the peroxisomal compartment of 
  murine primary M with WT or Pex11 KO phenotype. 
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4.1. Transfer and establishing protocols for M experiments 
Up to now the effect of pro-inflammatory stimuli on the peroxisomal compartment of myeloid 
cells has not been investigated. Therefore, all techniques regarding the exploration of the 
peroxisomal compartment had to be adjusted from hepatocytes to the isolation and enrichment 
of peroxisomes in M. Consequently, the first experiments were designed to transfer 
established protocols of hepatic peroxisome enrichment to the model organism of this thesis, 
the murine M cell line RAW264.7. 
 
4.1.1 Effect of cell sample freezing on enrichment of peroxisomal 
proteins 
According to the protocol for peroxisome enrichment and purification from rat liver of Völkl 
et al. [198] the use of freshly isolated liver cell samples for homogenization was 
recommended. However, it was noted that the homogenisation of RAW cells was not 
complete and a large amount of cells pelleted at 100 g and were lost for further centrifugation 
steps as shown by Western blot analysis using antibodies against peroxisomal proteins. Even 
after careful rehomogenisation of the 100 g pellet, cells were still lost in the first pellet. Since 
it was suggested from the literature that freezing and thawing of cells can lead to improved 
homogenisation, we tested out whether one freeze/thaw cycle would affect the peroxisome 
enrichment after centrifugation in comparison to enrichment of peroxisomes from freshly 
harvested cells (see Material and Methods, p.49).  
 
 
 
 
 
 
 
Fig. 10 Summary plates of Western blot analyses of cellular fractions from fresh or frozen RAW264.7 M.  
Cell homogenates of A) freshly harvested (fresh) or B) over-night at -80°C frozen cells (frozen) were fractionated by 
repeated centrifugation steps with increasing velocities (100 g, 1,950 g, 23,500 g). After each centrifugation step, each 
sample of supernatant (S1, S2 or S3) and pellet (P1, P2 or P3) was frozen in liquid nitrogen for Western blot analysis.  
10 µg protein of each fraction was separated on 12 % SDS-polyacrylamide gels and subjected to immunoblot analysis 
with appropriate antibodies. The picture shows a representative result of n=3 experiments. 
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In fresh RAW cell samples most of the investigated proteins (PEX14p and catalasewere 
located in the pellet P1 (Fig. 10A). In contrast, the investigated proteins in frozen cell samples 
were equally distributed between P1 and S1, suggesting a higher yield of free organelles. 
Indeed, Western blots of the frozen RAW264.7 cell samples revealed that most of the 
peroxisomes are mainly enriched in the 23,500 g pellet and no catalase protein was released 
from the peroxisomal matrix into the supernatant S3, suggesting that a very good and smooth 
isolation protocol for the mechanical sensitive organelle “peroxisome” has been established. 
Although a few large peroxisomes sediment in the pellet of heavy mitochondria (P2), most of 
the small and medium sized peroxisomes were recovered within the expected fraction (P3), 
which will further be called “enriched peroxisomal fraction”.  
After 23,500 g centrifugation, the Western blot bands for PEX14p and catalase in P3 from the 
frozen cell sample had the highest specific protein abundance in comparison to fresh cell 
sample. These findings indicated that one freeze/thaw cycle of RAW264.7 cell samples before 
homogenisation is beneficial for the homogenisation procedure and the peroxisome 
enrichment and detection of peroxisomal proteins in Western blot analysis. 
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4.1.2 Influence of different centrifugation velocities on peroxisome 
enrichment 
The classical protocol for peroxisome enrichment suggested a velocity of 1,950 g for the 
second differential centrifugation step to separate peroxisomes from larger mitochondria 
[198]. As stated above, this protocol is related to the enrichment of peroxisomes from rat liver 
hepatocytes in which peroxisomes are larger than in M [1, 211]. To optimise the protocol 
for RAW264.7 mouse MΦ and to take the difference between peroxisomes size in RAW264.7 
and hepatocytes (smaller/larger, lighter/heavier or lower/higher density) into account, 
different velocities (1,950 g, 5,000 g and 10,000 g) for the second centrifugation step were 
tested to determine its effect on organelle separation (mitochondria/peroxisomes) and on 
peroxisomal enrichment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 Summary of Western blot analyses of cellular fractions of RAW264.7 after centrifugation at different 
velocities during the second centrifugation step.  
Cell homogenates of frozen cells (over-night at -80°C) were fractionated by differential centrifugation with increasing 
velocities: 100 g for all samples (A-C), (A) 1,950 g (B) 5,000 g or (C) 10,000 g, followed by centrifugation at 23,500 g 
for all samples (A-C). After each centrifugation a sample of supernatant (S) and pellet (P) was frozen in liquid nitrogen 
for Western blot analysis. 10 µg protein of each fraction was separated on 12 % SDS-polyacrylamide gels and subjected 
to immunoblot analysis with appropriate antibodies. The picture shows a representative result of n=3 experiments. 
 
 
 
Doctoral Thesis  Andreas Kollas 
Institute of Anatomy and Cell Biology   
 
58 
Comparing supernatants and pellets after the distinct second centrifugation steps, a shift of the 
protein bands from the pellet P3 into pellet P2 of all investigated proteins (see Fig. 11) was 
noted, especially at higher velocities (5,000 g and 10,000 g). For PEX14p, this shift was most 
prominent. The protein bands of the P3 preparations (23,500 g) became less intense after 
higher velocities in the second differential centrifugation step (P2) (Fig. 11 B, C). This 
indicates that despite their different size peroxisomes in RAW264.7 do not behave differently 
from peroxisomes in rat hepatocytes regarding their centrifugation characteristics. Indeed, 
there was no improvement of peroxisome enrichment in P3 after centrifugation with velocities 
higher than 1,950 g in the second differentiation step.  
To conclude, we were not able to improve the separation of peroxisomes originating from 
RAW264.7 mouse MΦ with higher velocities than 1,950 g in the second differential 
centrifugation step. According to these results, for all following peroxisome isolations, except 
for the use of frozen cells for the homogenization procedure, the original enrichment protocol 
was applied as previously reported by Völkl et al. for rat liver peroxisomes [198]. 
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4.1.3 Effect of serum containing versus serum free medium on LPS or 
TPA induced mRNA expression of pro-inflammatory marker genes 
It is known that the peroxisomal compartment reacts very sensitive on changes in the 
metabolic state of cells, such as starvation or changes in medium composition [212-214]. 
Moreover, it was reported, that the M response to inflammatory stimuli changes in the 
presence or absence of FCS in the medium [215]. Due to these reasons, the mRNA expression 
of the inflammatory marker genes COX-2 and iNOS was compared in different medium 
conditions and in response to different pro-inflammatory stimuli. Since in many of the LPS-
experiments with M time points between 6 h and 24 h were used, the same treatment 
periods were used to test the effects of medium differences. RAW264.7 M were incubated 
for indicated periods in DMEM with or without 10 % FCS and the inflammatory response 
was induced by stimulation with 1.0 µg/ml or 0.5 µM TPA respectively. 
 
 
 
 
 
 
 
 
 
 
Fig. 12 mRNA expression of pro-inflammatory marker genes in different medium conditions induced 
by distinct inflammatory stimuli.  
RAW264.7 cells were cultivated in DMEM medium with or without 10 % FCS. Cells were treated for indicated time 
periods with 1.0 µg/ml LPS or 0.5 µM TPA. The inflammatory response induced by LPS or TPA was analyzed by RT-
PCR of pro-inflammatory marker genes COX-2 and iNOS. Samples were separated on 2.0 % agarose gels by gel 
electrophoresis, 45 min at 90 V. Equal sample loading was confirmed by 28S rRNA. The picture shows a representative 
result of n=3 experiments. 
 
According to these findings, a robust induction of expression of COX-2 mRNA after LPS 
treatment in FCS-containing and FCS-free media was noted. COX-2 mRNA steady state 
levels were slightly higher in serum containing medium. It is noteworthy, that iNOS induction 
after LPS simulation was even higher under Serum conditions. Moreover, an increase of 
iNOS expression was observed at later time points. TPA treatment did induce a lower effect 
on COX-2 mRNA expression. Furthermore, TPA did induce a slight iNOS mRNA increase. 
Due to these results, all following experiments with RAW264.7 cells were performed in 10 % 
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FCS-containing medium to prevent long-term starvation effects on the peroxisomal 
compartment. Moreover, LPS was used in the following experiments as pro-inflammatory 
stimulus because this set up showed the most prominent pro-inflammatory response. 
 
4.1.4 Confirmation of LPS induced activation of RAW264.7 cells by CD68  
LPS is a known inducer of the pro-inflammatory response and its usage in different cell 
culture model systems is well described. As a positive control and a marker for RAW264.7 
activation in Western blot analysis, we used an antibody against CD68. It was described that 
CD68 protein expression is increased during the inflammatory response of MΦ [216]. The 
function of CD68 is not yet discovered in total. However, it is a member of the 
lysosomal/endosomal-associated membrane glycoprotein (LAMP-) family and also a member 
of the scavenger receptor family [217]. Members of this family are typically related to 
clearance of cellular debris and are related to promotion of phagocytosis [218]. RAW 264.7 
cells were treated with 1.0 µg/ml LPS (see material and methods) for different time points (6 
h and 24 h) to investigate the effects of LPS on the activation of the M response to the pro-
inflammatory response of stimuli. 
 
 
 
 
Fig. 13 LPS mediated CD68 induction after activation of RAW264.7 cells.  
After incubation with 1.0 µg/ml LPS for indicated periods, 10 µg protein of RAW264.7 cell homogenate samples were 
separated on 12 % SDS-polyacrylamide gels and subjected to immunoblot analysis with an anti-CD68-antibody 
 
In untreated cells a fine band of the CD68 protein was visible at all time points (Fig. 13), 
which did not change over time. After LPS-treatment, an increased CD68 protein abundance 
was noted, with highest induction after 24 h (Fig. 13). Due to the results of this and the 
previous chapter, it was concluded that in RAW264.7 cells a pro-inflammatory response was 
initiated after LPS treatment. Because the highest CD68 protein expression was observed at 
24 h and peroxisomal half-life has been described to be nearly three days, incubation times of 
24 h or longer were used for further experiments. 
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4.1.5 Effect of LPS on mRNA expression of pro-inflammatory genes in 
RAW264.7 cells at later time points 
As a positive control, demonstrating the LPS induced long-term effect on M the mRNA 
expressions of the COX-2, iNOS and the TNF gene were analysed by RT-PCR after 24 h,  
48 h and 72 h LPS stimulation of RAW264.7 cells. 
 
 
 
 
 
 
Fig. 14 mRNA expressions of LPS-responsive genes after elongated treatment periods.  
RAW264.7 cells were incubated for indicated periods with or without 1.0 µg/ml LPS. After isolation of total mRNA, 
RT-PCRs with appropriate primer pairs were conducted. Equal amounts of the PCR products of each sample were 
separated in 2.0 % agarose gels. The figure shows a representative result of n=3 experiments. 
 
A marked induction of COX-2 and iNOS mRNA expressions was noted in comparison to the 
less intense TNF increase at all time points after treatment with 1.0 µg/ml LPS. The 
expression levels reached a clear peak at 48 h and decreased thereafter (Fig. 14). In 
comparison to the COX-2 mRNA expression, iNOS showed a later and stronger increase in 
LPS treated RAW264.7 cells. In untreated RAW264.7 a continuous expression of TNF 
mRNA on a low level was noted, which did not change during the duration of the experiment. 
LPS treatment increased the TNF mRNA expression at the indicated time points less 
pronounced, reaching its peak also at 48 h.  
In conclusion, a robust pro-inflammatory response of RAW264.7 cells after treatment with 
1.0 µg/ml LPS at later time points was noted, reaching its peak of gene activation after 48 h. 
Therefore, in all following experiments these time points were used to analyse changes of 
genes for peroxisomal proteins induced by the pro-inflammatory response in RAW264.7 
cells. 
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4.1.6 Experiments with primary murine wild type MΦ 
To analyse whether the effects of LPS treatment on the peroxisomal compartment and 
dependent gene expression are RAW264.7 cell line specific artefacts, alveolar and peritoneal 
MΦ were isolated from WT C57/BL6 mice and incubated with or without 1.0 µg/ml LPS. As 
a read out, the before mentioned pro-inflammatory marker genes were analysed by RT-PCR. 
4.1.6.1 Purity of the isolated murine WT alveolar and peritoneal macrophages 
After alveolar M isolation according to the protocol of Zhang et al. [194] or peritoneal MΦ 
based on the one of Ray et al. [195], the purity of the isolated adherent cells was revealed by 
immunofluorescence staining for CD68. As described earlier, this marker protein is present in 
all M and indicates phagocytic activity. In Fig. 15 A (next page), it is clearly visible that 
nearly all stained nuclei of adherent cells derived from alveolar lavage preparations are 
surrounded by CD68 positive immunostaining. The same is true for peritoneal MΦ, 
originating from peritoneal cavity lavage (Fig. 15 B). This indicates that the vast majority of 
the adherent cells are MΦ. Only a negligible part of the adherent cells are of different cellular 
origin. Approximately 1.5x10
6 
peritoneal M in comparison to 5x105 alveolar M were 
isolated per adult mouse. Therefore, for all following experiments mainly peritoneal M were 
used. 
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Fig. 15 CD68 immunofluorescence staining of isolated murine A) alveolar and B) peritoneal M: 
After isolation, A) murine alveolar and B) peritoneal M were plated and cultured for 24 h to adhere. After washing non 
adherent cells were removed and the primary cells were fixed with 4 % paraformaldehyde fixative. Macrophages were 
detected with the anti-CD68 antibody. Nuclear counterstaining was done with Hoechst 22358. The bars represent 100 
µm. 
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4.1.6.2 LPS experiments to visualise primary M activaion 
In order to compare the pro-inflammatory response of peritoneal WT MФ after 1.0 µg/ml LPS 
treatment in serum-containing medium to the reaction of RAW264.7 cells, RT-PCR analyses 
for the corresponding pro-inflammatory marker genes (COX-2, iNOS and TNFα) as for 
RAW264.7MФ were performed. 
 
Fig. 16 Effect of LPS on mRNA expression of COX-2, iNOS 
and TNF in peritoneal WT M. 
Isolated murine peritoneal WT M were incubated for indicated 
periods with or without 1.0 µg/ml LPS. After total mRNA 
isolation, RT-PCRs with appropriate primer pairs were conducted 
with 1.0 µl of each DNA sample. Equal amounts of the PCR 
products of each sample were separated in 2.0 % agarose gels. 
Loading control was against the product of the primer pairs of the 
house keeping gene Gnb2l. The figure depicts representative 
results of n=3 experiments. 
 
 
Fig. 16 shows, that the isolated unstimulated peritoneal MФ exhibited already a basal 
expression of COX-2 and TNFα mRNAs at both time points, with lower levels at 48 h 
compared to 24h. In contrast, iNOS expression was undetectable in the absence of LPS. After 
LPS treatment strong increases of COX-2, iNOS and TNFα mRNA expression levels were 
observed at both time points. These results indicate, that isolated peritoneal MΦ show a strong 
pro-inflammatory response to LPS treatment. In contrast to RAW264.7 cells, isolated 
peritoneal MΦ showed a stronger increase of TNFα mRNA expression after LPS treatment 
and an earlier peak of mRNA expression for all pro-inflammatory marker genes. However, 
the basic mRNA expression pattern of investigated inflammatory maker genes in isolated 
peritoneal MΦ and RAW264.7MΦ is comparable.  
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4.2. Effect of LPS or oxLDL treatment on the peroxisomal 
compartment of RAW264.7 and primary mouse M 
4.2.1 Effect of LPS on mRNA expression of genes encoding peroxisomal 
proteins * 
After establishing optimal conditions and time points for the detection of inflammatory 
response in RAW264.7, the influence of LPS treatment on the mRNA expression levels of 
different marker genes for peroxisomes (“peroxisomal genes”) were analysed by RT-PCR. In 
order to visualise the alterations on peroxisomal functions, the mRNAs for genes encoding 
catalase (Cat, ROS degradation), thiolase A (Acaa1, peroxisomal -oxidation), ABCD3 
(Abcd3, fatty acid transport and PEX11 (Pex11, peroxisomal proliferation) and PEX13 
(Pex13, peroxisomal matrix protein import) were analysed. Moreover, PLP-1 mRNA was 
analyzed, encoding a protein binding to PEX11 and involved in peroxisomal and 
mitochondrial division. Prolonged LPS incubation times were used to analyse the changes 
during the resolution phase of an acute inflammation. 
 
 
Fig. 17 The mRNA expression profiles for peroxisomal genes after LPS treatment. 
RAW 264.7 cells were incubated for indicated periods with or without 1.0 µg/ml LPS. After isolation of total mRNA, 
RT-PCRs with appropriate primer pairs were conducted. Equal amounts of the PCR products of each sample were 
separated in 2 % agarose gel. 28s rRNA served as internal control. Picture depicts representative results of n=3 different 
experiments  
 
 
* After submission of this thesis, I was informed that the results from the biphasic reaction of the peroxisomes 
induced by LPS stimulation could not be reproduced by another investigator. Respective reasons are unclear and 
should be clarified in further investigations. 
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Overall, clear effects of LPS treatment on the expression of most genes encoding proteins 
involved in peroxisome metabolism and proliferation were noted. After 24 h LPS treatment, 
the expression of Pex11 and Pex13 mRNAs did not change (Fig. 17) while the mRNA levels 
for all other investigated genes were decreased compared to untreated controls. After 48 h 
LPS treatment the mRNA expressions for Pex11, Abcd3 and Dlp-1-mRNAs were increased 
compared to untreated controls, whereas Pex13, Cat and Acaa1 mRNA levels in treated cell 
samples were equal to the expression levels of untreated cells. After 72 h incubation with 
LPS, expression levels of all investigated mRNAs were higher than in untreated controls.  
Since Pex11 and Dlp-1 are both genes involved in peroxisomal proliferation, this was a first 
hint that peroxisomes might divide during the late phase of the LPS induced inflammatory 
response. At later time points (72 h) peroxisomal gene expression was increased compared to 
control values.  
4.2.2 Effect of LPS treatment on expression of peroxisomal genes in WT 
murine peritoneal M  
Isolated WT murine peritoneal MΦ were treated with or without 1.0 µg/ml LPS (serum-
containing conditions) and subjected to RT-PCR analysis after total mRNA isolation. Since 
from primary M only a limited amount of cDNA could be obtained, RT-PCR for Pex11, 
Cat, and Acaa1 was performed. Alterations of Pex11, Cat and Acaa1 mRNA expressions are 
presented in Fig. 18. 
 
 
 
 
 
 
 
Fig. 18 mRNA expression profile for peroxisomal genes in peritoneal M after LPS treatment.  
Isolated murine peritoneal WT M were incubated for indicated periods with or without 1.0 µg/ml LPS. After mRNA 
isolation, RT-PCRs with appropriate primer pairs were conducted. Equal amounts of the PCR products of each sample 
were separated in 2.0% agarose gels. The picture depicts representative result of n=3 experiments. 
 
LPS treatment for 24 h of WT peritoneal M led to reduced Pex11α and Acaa1 mRNA levels 
whereas Cat was only slightly changed. After 48 h incubation, the expression levels of all 
investigated genes were higher in treated in comparison to untreated cells. This effect was 
also visible after 72 h incubation.  
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Comparing these results with the ones of RAW264.7, it is evident, that the mRNA expression 
pattern of RAW264.7 (Fig. 17) and WT peritoneal mouse MΦ (Fig. 18) after LPS stimulation 
is comparable, although it is not as pronounced in WT peritoneal mouse MΦ.  
Indeed, peritoneal M should not be sensitive against LPS, since LPS might originate from 
the physiological bacterial colonization of the colon. In summary, the results indicate that a 
common basic behavioural pattern of the mRNA expression for genes of peroxisomal proteins 
is found in these types of M. 
4.2.3 Effect of LPS on peroxisomal protein abundance 
Western blot analyses of LPS treated or untreated RAW264.7 MΦ was performed to analyse 
whether mRNA expressions correlated well with the corresponding peroxisomal protein 
abundances.  
 
Fig. 19 Summary of Western blot analyses 
of LPS treatment of RAW264.7 M and its 
effect on peroxisomal protein abundance.  
RAW 264.7 were incubated for indicated 
periods with or without 1.0 µg/ml LPS. 
Protein samples of whole cell homogenates 
(5.0 µg) were separated on a 12 % SDS-
polyacrylamide gel and subjected to 
immunoblot analyses with appropriate 
antibodies. Representative pictures of n=3 
different experiments are depicted. 
 
 
According to the results of the Western blot analyses (see Fig. 19) a strong decrease in 
catalase as well as thiolase protein abundance in RAW264.7MΦ after 24 h LPS treatment was 
noted. In contrast, PEX14p protein expression was increased after 24 h incubation with LPS. 
After 48 h the catalase protein almost recovered to control levels. Thiolase was less reduced 
in comparison to 24 h. Interestingly, the protein abundance for PEX14p was further increased 
after 48 h LPS treatment, indicating eventually a relative change in the content of surface 
membrane proteins to peroxisomal matrix proteins, suggesting a difference in peroxisomal 
structure. 
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4.2.4 Effect of LPS on peroxisome morphology and numerical abundance 
As shown in RT-PCR and Western Blot analyses, LPS exerts a great impact on peroxisomal 
mRNA expression and protein abundance. To visualise the morphological changes within the 
peroxisomal compartment during LPS treatment, immunofluorescence staining of RAW264.7 
cells after 24 h and 48 h LPS [1.0 µg/ml] incubation periods were prepared. Antibodies 
against the peroxisomal membrane protein PEX14p and the peroxisomal matrix protein 
catalase were used to analyse differences in organelle number and organelle morphology. 
After 24 h LPS incubation, RAW264.7 cells were increased in size and shape compared to 
untreated controls. Untreated RAW264.7 cells exhibited a more monocytic phenotype, 
whereas LPS-treated cells resembled activated M. Moreover, peroxisome number in LPS 
treated cells increased in staining for both, PEX14 as well as catalase, compared to untreated 
control samples (see Fig. 20 A+B, E+F). After 48 h LPS treatment, additional structural 
changes appeared in cell morphology of treated RAW264.7 cells with stretching out and 
flattening and exhibition of filopodia and large vacuoles. These changes were accompanied by 
a tremendous increase in peroxisome number. Whereas the peroxisomes were spread out 
through the cytoplasm with some aggregates of organelles near the nucleus after 24 h 
incubation, most of these organelles exhibited a more perinuclear distribution and formed 
large clusters after 48 h LPS treatment. Moreover, several peroxisomes were located in close 
neighbourhood to vacuoles, leading to spherical arrangements of many individual organelles 
within the cytoplasm (see Fig. 20 C+D, G+H). This pattern was observed in both 
preparations, for PEX14p as well as catalase.  
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Fig. 20 Immunofluorescence  stainings of RAW264.7 cells for peroxisomal proteins.  
Stainings of RAW264.7 cells for catalase (A-D) or PEX14p (E-H) (green). Cells were incubated for 24 h (A+B, E+F) or 
48 h (C+D, G+H) with 1.0 µg/ml LPS (B+D, F+H) or without (A+C, E+G). Pictures show representative 
immunofluorescence micrographs of 3 different experiments. Nuclei were counterstained with Hoechst 22358 (blue). 
Bars represent 20 µm. 
 
Peroxisomes in each individual cell were counted (30-50 cells/sample) to quantify the 
peroxisomal changes. Indeed, already after 24 h LPS treatment, peroxisome number doubled 
in catalase and PEX14p stained cells compared to untreated controls (see Fig. 21). After 48 h 
LPS treatment, the peroxisome number increased seven fold in comparison to untreated 
control samples. Calculations using the two sided unpaired students`s t-test revealed that the 
increase of peroxisome number after 48 h was highly significant compared to corresponding 
untreated controls.  
 
 
 
 
 
 
 
 
Fig. 21 Peroxisome abundance in RAW264.7.  
Cells were fixed with 4 % paraformaldehyde after indicated periods of incubation with or without LPS [1.0 µg/ml]. 
Peroxisomes were counted in cells in which individual peroxisomes could be identified. Cells with clusters, where 
individual organelles could not be resolved were not taken into consideration. 30-50 cells per experiment and treatment 
(n = 3) were analysed. Software aided counting with the “imageJ” software of catalase or PEX14p labelled particles per 
individual cell. Bars represent the mean number of peroxisomes/cell +/- standard deviations. *** = p < 0.001 Student`s t-
test. 
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4.3 Treatment of RAW264.7 cells with proatherogenic oxidized LDL 
particles in comparison to LPS 
Atherosclerosis is a chronic inflammatory disease of the arterial wall, in which M are 
activated in the sub-endothelial intima by oxidized LDL particles (oxLDL) [189]. To compare 
the effects of different types of M activation on the peroxisomal compartment, RAW 264.7 
cells were incubated with different concentrations of oxLDL. Effects of the oxLDL treatment 
were compared with the effects after LPS treatment. 
 
4.3.1 Long-term effect of oxLDL or LPS on mRNA expression of 
inflammation-related marker genes 
Since peroxisomes contain different enzymes which are involved in ROS-degradation and  
β-oxidation of a large variety of complex lipids, it was hypothesised, that peroxisomes in MΦ 
play an important role during formation of foam cells and progression of oxLDL driven 
inflammatory changes of the arterial intima during atherosclerotic processes (for a review see 
[189]). To compare the effects of oxLDL and LPS on M activation and peroxisomal 
alterations, RAW264.7 cells were incubated with distinct concentrations of oxLDL (12.5 
µg/ml, 25 µg/ml and 50 µg/ml) in comparison to 1.0 µg/ml LPS for 24 h and 48 h in serum 
containing medium. The mRNA expressions of the different pro-inflammatory marker genes 
(COX-2, iNOS, TNF and HO-1) were analysed by RT-PCR. 
 
Fig. 22 mRNA expression of 
pro inflammotry genes after 
LPS or oxLDL treatment. 
RAW 264.7 cells were 
incubated for indicated periods 
with 1.0 µg/ml LPS or 
increasing concentrations of 
oxLDL (12.5 µg/ml, 25.0 
µg/ml, 50.0 µg/ml). After 
isolation of mRNA, RT-PCR 
with appropriate primer pairs 
was conducted. Equal amounts 
of the PCR products of each 
sample were separated in 2.0 % 
agarose gel. Representative 
picture of n=3 different 
experiments. 
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In comparison to the robust increase of mRNA expressions of all investigated pro-
inflammatory genes after 24 h and 48 h LPS treatment (Fig. 22), incubation of RAW264.7 
with oxLDL induced only a marked increase of COX-2 after 24 h and TNF after both 
incubation periods. This effect was only visible at the highest oxLDL concentration (50.0 
µg/ml). OxLDL incubation exerted hardly any effect on iNOS mRNA expression (Fig. 22). 
In contrast to pro-inflammatory genes, all concentrations of oxLDL induced a clear increase 
of the HO-1 mRNA, a gene known to be up regulated during M activation with different 
stimuli [222]. Moreover, levels of HO-1 and TNF mRNAs increased with increasing oxLDL 
concentrations. According to these results, a concentration of 50.0 µg/ml oxLDL was used for 
RAW264.7 activation in further experiments. 
 
4.3.2 Effects of oxLDL in comparison to LPS on peroxisomal protein 
abundance 
After determine the working concentration of 50.0 µg/ml oxLDL, RAW264.7 cells were 
incubated for 24 h or 48 h with this concentration. To compare the effects of oxLDL with the 
effects of LPS on the protein expression of peroxisomal proteins, the cells were incubated 
with 1.0 µg/ml LPS for indicated time periods. Western blot analyses were performed using 
antibodies against catalase, thiolase, ABCD3 as well as PEX13p and PEX14p to determine 
protein abundance of peroxisomal proteins. 
 
 
 
 
 
 
 
 
 
Fig. 23 Summary of Western blot analyses of the effects of oxLDL or LPS on peroxisomal protein abundance.  
RAW264.7 cells were incubated for indicated periods with or without 50.0 µg/ml oxLDL or 1.0 µg/ml LPS. Cell 
homogenates of frozen cell samples were fractionated. 5.0 µg protein each of the enriched peroxisome fractions P3 were 
separated on 12 % SDS-polyacrylamide gels and subjected to Western blot analyses with appropriate antibodies. 
Representative picture of n=3 different experiments are depicted. 
 
In comparison to the control sample, incubation of RAW264.7 with 50.0 µg/ml oxLDL for  
24 h or 48 h respectively, led to a clearly visible increase of catalase protein level (Fig. 23) in 
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contrast to the strong decrease in the LPS treated samples. Whereas all protein levels of 
thiolase seemed to be unchanged at both time points after oxLDL treatment (Fig. 23). 
Similarly, the protein levels of the fatty acid transporter ABCD3 was hardly altered after 24 h, 
whereas it was slightly increased after 48 h oxLDL treatment. In contrast, thiolase and 
ABCD3 proteins were clearly decreased after LPS treatment. PEX14p does not seem to be 
affected by oxLDL and might be increased slightly only after 24 h oxLDL treatment. 
According to these results, oxLDL induces a different response on mRNA level of pro-
inflammatory genes than LPS and an opposite effect on peroxisomal metabolic marker 
proteins. 
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4.4 Effects of TLR-4-, NFB- and TNFR- inhibitors on the LPS-
induced alterations of the peroxisomal compartment 
Inhibitors against critical elements of the LPS signal transduction were used to investigate the 
underlying signalling pathway, since incubation of RAW264.7 with LPS led to changes in 
peroxisomal mRNA expression and protein abundance as well as induces peroxisome 
proliferation. The first step in the pro-inflammatory LPS response is the recognition of LPS 
by its receptor TLR-4. CLI-095 (blocking the binding of LPS with TLR-4) was used to inhibit 
LPS recognition. Celastrol was applied to inhibit the NFB-mediated signal transduction. 
Finally, to exclude the possibility of autocrine TNF activation, the TNF-R inhibitor SPD-
304 was used. 
 
4.4.1 MTT-test: Effect of CLI-095, celastrol and SPD-304 on cell viability 
An initial experiment with the above mentioned inhibitors revealed, that the concentrations of 
celastrol and SPD-304 which were suggested by the manufacturer, were toxic for RAW264.7 
at the time points of our interest (24 h, 48 h, 72 h). up to then, most experiments performed 
with these inhibitors used time periods up to 12 h. Therefore, the concentrations had to be 
reduced to a non-toxic level for longer incubation periods. To determine the maximum 
working concentration for each inhibitor, RAW264.7 cells were incubated for 24 h with 
increasing concentrations of the appropriate inhibitor as indicated in Fig. 24. The effects of 
the used inhibitors on cell viability were measured via the MTT-assay as described in 
Material and Methods, p .45.  
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Fig. 24 Effect of inhibitors of inflammatory signalling pathways on cell viability. 
RAW264.7 cells were incubated for 24 h with indicated concentrations of respective inhibitors. Viability of control =1. 
Mean values of n=3 independent experiments are depicted. Error bars = S.D.  
 
According to these results, CLI-095 can be used at concentrations up to 18 µM without any 
negative effects on cell viability (see Fig. 24 A). The proposed working concentration of the 
company for celastrol was 2.5 – 10.0 µM. Although much lower concentrations were used 
(see Fig. 24 B), a dose dependent increase in cell toxicity at these concentrations was 
observed. According to these results, we used a celastrol concentration of 0.03 µM in all 
following experiments. The incubation of RAW264.7 with SPD-304 showed a dose 
dependent increase in cell toxicity (Fig. 24 C) represented by a decrease in cell viability. For 
all further experiments, a SPD-304 concentration of 1.0 µM was used. According to the 
results of the toxicity tests, lower concentrations of celastrol (0.03 µM) and SPD-304 (1.0 
µM) than recommended from the manufacturer were used, wherefore their inhibitory potency 
on the NFB and TNF signalling pathways might not be complete. 
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4.4.2 Effects of inhibitors on mRNA expression on pro-inflammatory 
marker genes 
RAW264.7 cells were incubated with or without 1.0 µg/ml LPS or coincubated for 24 h with 
or without 1.0 µg/ml LPS and CLI-095 [18.0 µM], celastrol [0.03 µM] or SPD-034 [1.0 µM], 
respectively. The inhibition of LPS-induced gene expression by the distinct inhibitors was 
analysed by RT-PCR for the pro-inflammatory maker genes COX-2 or iNOS, respectively. 
 
Fig. 25 Effects of CLI-095, 
celastrol or SPD-034 on the 
mRNA expression of COX-2 
or iNOS after LPS treatment. 
RAW264.7 cell were treated 
with or without 1.0 µg/ml LPS. 
Coincubation with CLI-095 
[18.0 µM], Celastrol [0.03 µM] 
or SPD-034 [1.0 µM] for 24 h. 
RT-PCR was performed with 
corresponding primer pairs. 
Equal amounts of the PCR 
product were separated on 2.0 % 
agarose gels. Figure represents 
the result of n = 3 experiments. 
 
As seen before (see Fig. 14), treatment of RAW264.7 cells with LPS led to increased COX-2 
and iNOS mRNA expressions (Fig. 25). Coincubation of the cells with LPS and CLI-095 or 
celastrol blocked COX-2 mRNA expression nearly completely, only faint bands were 
detectable in comparison to the “LPS only” treated sample. The expression of iNOS mRNA 
was completely inhibited. The effect of SPD-034 conicubation was less pronounced compared 
to CLI-095 and celastrol, although clear reduction of COX-2 and iNOS mRNA expression 
was noted. The incubation of RAW264.7 cells with the inhibitors alone induced no mRNA 
expression of COX-2 or iNOS.  
According to these results, TLR-4 and NFB signalling was convincingly blocked during 
LPS incubation. It is not suprising, that the coincubation of SPD-034 did not completely block 
of COX-2 or iNOS mRNA expression after LPS treatment, since it the initial induction of 
COX-2 and iNOS is not primarily mediated by TNF but rather by TLR-4/NFB activation. 
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4.4.3 Effect of inhibitors of pro-inflammatory signalling pathways on 
levels of peroxisomal proteins  
RAW264.7 cells were incubated with or without 1.0 µg/ml LPS for 24 h, 48 h and 72 h. 
Additionally, RAW264.7 cells were coincubated with 1.0 µg/ml LPS and either 18.0 µM 
CLI-095 or 0.03 µM celastrol or 1.0 µM SPD-304. After preparation of whole cell lysates, 
equal amounts of proteins from each sample were used to perform Western blot analyses. 
 
Fig. 26 Summary of Western blot 
analyses of the effects of pro-
inflammatory pathway inhibitors on LPS 
induced changes of the peroxisomal 
compartment. 
RAW 264.7 cells were incubated for 
indicated periods with or without 1.0 µg/ml 
LPS. Additionally, coincubation of  
1.0 µg/ml LPS and CLI-095 (18.0 µM), 
Celastrol (0.03 µM) or SPD-034 (1.0 µM) 
was performed. 10 µg protein of each whole 
cell lysate was separated on 12 % SDS-
polyacrylamide gels and subjected to 
immunoblot analysis with appropriate 
antibodies. Representative pictures of n=3 
different experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
As expected from previous experiments, incubation of RAW264.7 with LPS induced a 
decrease in protein levels of catalase, thiolase and ABCD3 at all investigated time points (Fig. 
26 A-C). In contrast, PEX14p was increased after LPS treatment at all time points (Fig. 26 D). 
Coincubation of CLI-095 with LPS prevented the reduction of catalase, thiolase and ABCD3 
at all investigated time points reliably (see Fig. 26 A-C). The protein levels of thiolase and 
ABCD3 after LPS+CLI-095 treatment were even higher as the corresponding controls (Fig. 
26 C, D). Interestingly, highest levels of catalase and thiolase proteins were obtained 
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especially after 24 h LPS+CLI-095 treatment. (Fig. 26 A). A similar effect was also noted by 
coincubation of LPS/celastrol and LPS/SPD-304 after 24 h. The PEX14p levels in LPS+CLI-
095 treated cells were equal to the ones of the untreated control at all time points (Fig. 26 D). 
Inhibitory effects of celastrol and SPD-304 were also detectable, especially after 24 h 
incubation but were less pronounced at 48 h and 72 h (Fig. 26 A-D). After 48 h and 72 h 
celastrol and SPD-304 also prevented LPS induced catalase reductions, brought them back to 
control levels (Fig. 26 A). Celastrol and SPD-304 did also prevent the LPS induced thiolase 
reductions, but seemed to increase thiolase levels above the ones of the untreated controls at 
24 h and 48 h (Fig. 26 B). After 72 h the thiolase levels in celastrol+LPS and SPD-304+LPS 
samples did not seem to be fully recovered in comparison to control levels (Fig. 26 B). 
Comparable effects were observed also for ABCD3. After 24 h, celastrol and SPD-304 
prevented the LPS mediated ABCD3 reductions (Fig. 26 C). In contrast after 48 h and 72 h 
the inhibitory effects of both chemicals were not as strong as the one for CLI-095. Moreover, 
CLI-095 prevented the LPS mediated increases of PEX14p at all time points (Fig. 26 D), but 
Celastrol and SPD-304 were not able to prevent this effect.  
In conclusion, the results indicate that all inhibitors were able to block the LPS mediated 
alterations of the investigated peroxisomal proteins. The effect of CLI-095 was strongest and 
most constant during all time points, whereas celastrol and SPD-304 exhibited their strongest 
effects only at 24 h.  
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4.5 Effect of a Pex11 KO on the inflammatory response of primary 
mouse M 
The observations regarding the effect of LPS on the peroxisomal compartment, especially the 
high induction of Pex11 gene expression, led to the question, whether the knockout of the 
Pex11 gene would affect the inflammatory response of M. For these experiments 
bonemarrow-derieved macrophages (BMDM) isolated from Pex11 KO mice, that were 
generated and characterized by our group before, were used [212]. 
 
4.5.1 Effect of LPS on the peroxisomal compartment in BMDM of WT and 
PEX11 KO mice 
To transfer the results obtained from RAW264.7 cells to primary M similar experiments as 
mentioned before were performed with BMDMs from WT animals. To analyse the effects of 
a Pex11KO on the LPS-response, BMDM from Pex11KO mice were processed in parallel.  
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Fig. 27 Influence of LPS on the peroxisomal compartment of WT and Pex11 KO M. 
Isolated BMDM from WT and PEX11 KO mice were plated on glass cover slips and treated for 24 h with or without 
1.0 µg/ml LPS. Primary antibody was directed against catalase protein. Nuclear counterstaining by Hoechst22358. 
Untreated A) WT and C) Pex11 KO M. Peroxisomes in treated WT M B) seem to be smaller, are present at a 
higher numerical abundance and exhibited a higher clustering than peroxisomes of LPS treated Pex11 KO M D). The 
bars represent 10µm.  
 
Structural changes of the peroxisomal compartment were analysed by catalase 
immunoflourescence staining of LPS-treated and -untreated WT or Pex11 KO BMDM. 
Despite the preincubation of BMDM for differentiation with M-CSF conditioned medium 
(DMEM) for a period of 5 days effects of M-CSF on the peroxisomal compartment would 
rather be expected at much earlier time-points, e.g. 24 h, as described also for other growth 
factors [223]. Peroxisomes in WT BMDM exhibited the typical spherical to rod shaped 
morphology present also in RAW264.7 cells under regular culture conditions. 
In BMDM isolated from Pex11 KO mice, peroxisomes appeared slightly larger, less 
numerous as well as more spherical in comparison to peroxisomes in WT BMDM. The 
peroxisomes in the WT cells were small, round to rod-shaped and exhibited a high numerical 
abundance and formed large clusters in the perinuclear region. Moreover, several “beads on a 
string” structures were noted, suggesting peroxisomal fission. This phenotype was 
comparable to the one observed in LPS treated RAW264.7 M.  
In contrast, the peroxisomes in LPS-treated Pex11 KO M appeared to be enlarged, 
exhibited a lower numerical abundance and formed smaller perinuclear clusters than their WT 
counterparts. Additionally, many “beads on a string” structures were present. Two cell 
biological processes might explain these phenomenons: 1) The elongated peroxisomes could 
either be stuck in the fission process or 2) the transport of already divided peroxisomes via 
binding to elements of the cytoskeleton could be impaired.  
In summary, LPS treatment seemed to induce peroxisomal fission and proliferation, which is 
impaired by the KO of the Pex11 gene. Moreover, during this experiment, another major 
difference between WT and Pex11KO BMDM was noted. After LPS treatment, more dead 
cells were observed in the medium of Pex11KO BMDM than in the medium of their WT 
counterparts. Therefore, cell survival after LPS treatment of WT compared to Pex11 M 
was analysed, using a LDH release-based cytotoxicity kit (Roche). 
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4.5.2 Effect of LPS on cell death or survival 
The LDH release based cytotoxicity test (Roche) was used to quantify the effect of LPS 
treatment on cell-survival and -damage. The LDH-release values were photometrical 
quantified and the cell survival was calculated according to the formula given by the 
manufacturers. The calculated values are depicted in Fig. 28.  
 
Fig. 28 Effect of LPS treatment on cell survival of 
WT (+/+) and Pex11 KO (-/-) BMDM. 
Isolated BMDM from WT or Pex11 KO animals 
were treated with or without 1.0 µg/ml LPS for 24 h. 
Thereafter 100 µl of the medium was removed and 
LDH assay were performed. The values of the 
untreated WT or KO cells were set to 100 %. KO 
M show an impaired gain of survival after LPS 
treatment. 
 
 
 
 
 
 
 
According to these results, the treatment of WT cells (+/+) led to an increased survival of LPS 
treated cells compared to untreated controls (Fig. 28). In contrast the Pex11 KO M showed 
no increase in cell survival after LPS treatment. The values of untreated WT and Pex11 KO 
M were at the same level. 
The increase of cell survival could be related to the activation of pro-survival signalling 
pathways like MAP kinases, such as p38, or Akt (also known as PKB) after LPS treatment 
[224]. Another possibility would be a changed activation of pro-apoptotic signalling 
pathways. Therefore, markers for activation of pro-apoptotic pathways were analysed.  
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 A) 
4.4.3 Bad expression in LPS treated WT and PEX11 KO M  
The first step was to check mRNA levels of Bad, a pro-apoptotic member of the Bcl family, 
which is involved in intrinsic induction of apoptosis in which a mitochondrial permeability 
transition pore (MPTP) is formed. Thereafter, cytochrome c is released from the 
mitochondria, inducing caspase-3 activation. During intrinsic apoptosis, Bad is involved in 
the formation of the MPTP.  
Due to material restrictions (missing specific antibody) only RT-PCR analysis of Bad mRNA 
expression but no Western blots could be performed. 
 
Fig. 29 A) Quantification of relative 
mRNA values for Bad.  
Intensity values for Bad mRNA of different 
samples were divided by the appropriate 
values for Gnb2l, a marker gene that has 
been shown in the literature not to be altered 
by LPS treatment.  
 
 
 
 
 
 
 
 
 B) 
B) Bad mRNA expression in WT and 
Pex11 KO BMDM after LPS 
treatment. 
Isolated murine BMDM from WT and KO 
animals were incubated for indicated 
periods with or without 1.0 µg/ml LPS. 
After mRNA isolation, RT-PCRs with 
primer pairs against Bad and Gnb2l as 
loading control were performed. Equal 
amounts of the PCR product of each 
sample were separated in 4.0 % agarose 
gels. Figure 28 B shows representative 
result of n=3 experiments. 
 
 
Indeed, Bad mRNA expressions were increased in Pex11 KO MΦ compared to WT cells at 
24 h and 48 h (Fig. 29 B), suggesting the activation of pro-apoptotic pathways in Pex11 KO 
MΦ. This effect was visible by comparing untreated WT and Pex11 KO cells. Bad mRNA 
expression was quantified in relation to the one of Gnb2l, a house keeping gene which was 
reported not to be altered after LPS treatment (Fig. 29 A). LPS-treatment did not exert a 
strong effect on Bad expression in WT and Pex11 KO M, when values were calculated in 
relation to Gnb2l. Higher general Bad expression levels in Pex11 KO BMDM might be one 
B) 
Doctoral Thesis  Andreas Kollas 
Institute of Anatomy and Cell Biology   
 
83 
of the reasons, why Pex11 KO MΦ cultures exhibit a higher cell death rate after LPS 
treatment compared to WT M cultures. 
4.5.4 Caspase-3 cleavage in LPS treated WT and PEX11α KO MΦ 
Activation of Bad occurs during intrinsic apoptosis pathway, whereas downstream lies the 
activation of the executioner caspase-3. Cleavage of procaspase-3 is a direct marker for 
caspase-3 activation. Western blot analysis of LPS treated WT and Pex11α KO MΦ was 
performed to analyse whether elevated levels of activated caspase-3 are present in Pex11 
KO M. An antibody against both parts of cleaved caspase-3 was used. 
 
 
 
 
 
 
Fig. 30 Summary of Western blot analyses of Effect of LPS treatment on Caspase-3 cleavage in WT and Pex11 
KO BMDM. 
Isolated BMDM from WT or Pex11 KO animals were incubated for indicated periods with or without 1.0 µg/ml LPS. 
4 µg protein each of whole cell lysate sample was separated on 15 % SDS-polyacrylamide gels and subjected to 
immunoblot analysis with an antibody against cleaved caspase-3. Representative picture of n=3 different experiments. 
These preliminary experiments should be validated in macrophages of a higher number of animals. 
 
According to the results of the Western blot analysis (Fig. 30), a decrease of cleaved  
caspase-3 in WT cells after 24 h due to LPS treatment is visible, which is not maintained after 
48 h. The reduced amount of activated cleaved caspase-3 protein might explain the increased 
cell survival of WT BMDM after LPS treatment, as shown before. In contrast, the level of 
cleaved caspase-3 in Pex11α KO MΦ seems to be increased after 24 h LPS treatment, which 
could explain the increased cell death. This effect is not present after 48 h LPS treatment. 
Long-term LPS treatment rather seems to have opposite effects on Pex11 KO BMDM. 
Doctoral Thesis  Andreas Kollas 
Institute of Anatomy and Cell Biology   
 
84 
4.5.5 Effect of LPS on the mRNA expression of pro-inflammatory marker 
genes of WT and PEX11 KO BMDM 
The Pex11α gene knock out exerts a tremendous effect on peroxisome morphology and cell 
survival after LPS treatment. The mRNA expression levels of inflammatory marker genes 
were analysed (COX-2, iNOS) in total RNA samples of WT and Pex11α KO BMDM after 48 
h LPS treatment [1.0 µg/ml] to answer the question, whether the Pex11 KO has an influence 
on the pro-inflammatory response after LPS treatment. Furthermore, isolated BMDM from 
male and female donor mice were cultivated separately to investigate gender specific effects 
on the expression of COX-2 or iNOS after LPS treatment. 
 
 
 
 
 
 
 
 
 
 
 
According to the PCR analyses the deficiency of the Pex11α gene exerted a clear impact on 
the expression levels of pro-inflammatory marker genes (see Fig. 31). Expression levels of 
COX-2 as well as of iNOS mRNAs are clearly increased in Pex11KO BMDM compared to 
WT cells. Furthermore BMDM of female mice exhibited higher expression levels of COX-2 
and iNOS mRNAs under untreated and after LPS treated conditions compared to their male 
counterparts.  
Fig. 31 mRNA expressions of pro-
inflammatory genes in murine 
primary BMDM after LPS 
treatment. 
Isolated murine WT or Pex11 KO 
BMDM were incubated for 48 h with 
or without 1.0 µg/ml LPS. After 
mRNA isolation, RT-PCRs with 
appropriate primer pairs were 
performed. Equal amounts of the PCR 
products of each sample were 
separated in 4.0 % agarose gel. Image 
shows representative result of n=3 
experiments. These preliminary 
experiments should be validated in 
macrophages of a higher number of 
animals. 
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5. Discussion 
Peroxisomes are ubiquitous organelles, however every organ and cell type investigated so far 
contains a very unique configuration of this organelle [211, 225]. Composition of membrane 
and matrix proteins differ between peroxisomes of different cell types, representing the wide 
spectrum of tasks peroxisomes fulfil. Most of the information on peroxisome morphology and 
physiology has been generated in liver, kidney or brain of rat, mouse or fibroblasts of human 
subjects or patients with peroxisomal diseases [4, 211, 226-231]. Although there are reports 
linking inflammatory processes to changed peroxisomal activity in various organs, especially 
in the brain, little is known about the effect of inflammatory processes on the peroxisomal 
compartment within one of the key cell types of the innate immunity, the 
monocyte/macrophage (M) [1, 232]. 
According to the different parts in the results section of this dissertation, the discussion is also 
structured in four different parts. 
1) During the experimental work of this thesis protocols for peroxisome isolation have been 
transferred and established to investigate the peroxisomal compartment in M. After 
establishing all necessary methods, the influence of inflammatory mediators on the 
peroxisomal compartment has been investigated.  
2) The results of this dissertation reveal a strong influence of M activation on peroxisomal 
gene expression as well as peroxisomal protein abundance, indicating a possible role of the 
metabolism of this organelle in inflammation regulation.  
3) The next set of experiments aimed at discovering the responsible signalling pathways, 
using pharmacological inhibitors against key factors of inflammatory signalling (TNF-R, 
NFB and TLR-4). 
4) Since a strong response of the Pex11 gene was found in different phases of the 
inflammatory response, isolated M originating from Pex11 gene knock out mice were used 
to investigate the influence of the gene knock out on the pro-inflammatory response in these 
cells, including the late resolution phase of the inflammatory reaction [212]. 
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5.1 Transfer and establishing protocols for M 
In order to investigate the effect of pro-inflammatory stimuli on the peroxisomal compartment 
of macrophages, methods for peroxisome enrichment in the liver had to be adapted and 
established for the isolation of these organelles in macrophages in our laboratory.  
The isolation of peroxisomes from whole cell lysate is a very useful tool to investigate the 
protein composition of peroxisomes. The transfer of the isolation protocol from the original 
publication from Völkl and Fahimi to M was the first step in investigating the peroxisomal 
compartment in this cell type [198]. In contrast to this study wherein whole rat liver 
homogenates were subjected to cell fractionation, cell lysates from murine RAW264.7 M 
were used in this dissertation. The cell line RAW264.7 has advantages compared to isolated 
M and is a well characterised immortal cell line. Cultivation can easily be performed 
continuously without the sacrifice of donor mice for alveolar or peritoneal M isolation. 
Moreover, the cell number of harvested RAW264.7 cells is much higher than from isolated 
alveolar or peritoneal M, allowing resource intensive experiments, such as subcellular 
fractionation by differential centrifugation and subsequent Western blot analyses. However, a 
well-known drawback of cell lines is a possible loss or alteration of functions due to long-
term cultivation, which might lead to mutations. Because of these reasons, additional 
experiments with isolated M from mice were performed, to compare the results between the 
RAW264.7 cell line and primary M of different origins (e.g. BMDMs, peritoneal or alveolar 
M) to exclude the possibility that the results represent cell line specific artefacts. 
In the publications referring to peroxisome enrichment from distinct tissues the use of fresh 
samples was recommended, since peroxisomes are very sensitive organelles [198, 199, 233, 
234]. However, in this thesis could be shown, that the use of a regular Elvehjem Potter or 
even a Dounce homogenizer for homogenisation of cell culture samples from RAW264.7 
cells is not advisable. RAW264.7 cells are small cells and only a very low volume of sample 
was available (100 µl) in comparison to the tissue samples used for the homogenisation 
procedure described in the literature (~20 ml for rat liver). By using the regular Potter-
Elvehjem homogenizer for the small volumes of M cell cultures, a large part of the sample 
was lost, because the plasma membrane of the M was not completely opened and the non-
broken cells pelleted down in the first centrifugation step. A careful literature analysis 
revealed that multiple cycles of freezing and thawing of the cell cultures, followed by 
shearing the cell samples through a 22 gauge needle were performed for M. However, these 
protocols, aimed at the isolation of other organelle types from M. Since 
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peroxisomes are very fragile organelles, from which matrix proteins leak out easily, the 
adaption of the original protocol to the isolation of these organelles in M had to be 
performed carefully. The results of this thesis indicate that one freeze/thaw cycle of the 
RAW264.7 cell samples before homogenisation with a Potter-Elvehjem homogenizer 
improves the peroxisomal enrichment by differential centrifugation compared to using fresh 
cell samples (p. 54) as well as preserves the integrity of peroxisomes and prevents matrix 
protein leakage out of these organelles. Another beneficial aspect of this method was the 
easier handling of the cell samples, because many cell culture samples could be stored at  
-80°C and pooled if necessary after the harvest until peroxisome enrichment and further 
protein analyses were performed.  
Another critical factor for peroxisome enrichment was the application of the correct 
centrifugation velocity for the separation of distinct organelles. For peroxisome isolation from 
rat hepatocytes a velocity of 1,950 g was recommended according to Völkl et al. [198] to 
separate peroxisomes from larger mitochondria. Since peroxisomes differ in morphology and 
protein composition between distinct organs of different species [1, 185, 227, 239-244], the 
effect of different velocities in the second step of the differential centrifugation procedure was 
investigated in RAW264.7 (p. 56). The results indicate that peroxisome enrichment is not 
improved using velocities higher than 1,950 g, wherefore for all subsequent experiments a 
centrifugation velocity of 1,950 g at the second centrifugation step was used. 
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5.2 Effect of pro-inflammatory stimuli on RAW264.7 M and primary 
mouse M 
5.2.1 Selection of the model system 
In order to create a robust inflammatory response in RAW264.7 M, we compared two 
different pro-inflammatory stimuli, LPS and TPA. Both stimuli have been used regularly for 
studying pro-inflammatory activation of different M cell lines and primary M in the 
literature [245-250]. By using these two stimuli distinct pathways of M can be investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32 Schematic overview of LPS and TPA induced macrophage activation.  
LPS induced M activation is mediated via TLR 4 signalling. After LPS binding NFB is released from 
IB, translocates into the nucleus and induces the expression of pro-inflammatory genes, such as COX-2. 
TPA mimics the PKC product diacylglycerol, activating Ras/Raf signalling and induces COX-2 expression 
via ERK. 
 
Since TPA mimics PKC-signalling downstream of diacylglycerol, this stimulus might be 
useful for further studies with Pex gene KO mice, in which the lipid components of the 
plasma membrane might be disturbed. Moreover, it has been described that phorbolesters may 
lead to peroxisome proliferation [251]. 
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In addition to these two stimuli, the effect of serum withdrawal on the inflammatory response 
was analysed. Most protocols suggested the use of serum withdrawal before stimulation of 
M [252, 253]. However, serum starvation is a very important factor influencing peroxisome 
metabolism. It is well known that the peroxisomal compartment changes in response to 
altered nutritional conditions (e.g. starvation and growth factors) [20, 212, 254-256]. Severe 
differences were noted in fact in this thesis when M were stimulated under serum or serum-
free conditions. Interestingly, the results indicate that LPS induces the most pronounced pro-
inflammatory response in RAW264.7 cells when incubated in serum containing medium  
(p. 58) and provide the first clear-cut evidence that indeed serum should be used to generate 
the strongest pro-inflammatory response. The incubation in serum containing medium does 
prevent starvation induced effects on the peroxisomal compartment during the inflammatory 
response, especially during long-term incubation (>24 h), after which M die by apoptosis 
under serum-free conditions (data not shown). For long-term experiments, e.g. to study the 
resolution of inflammation, serum addition is therefore a necessary requirement. 
 
5.2.2 Induction of the inflammatory response in RAW264.7 and primary 
mouse M 
The most critical step in investigating the effect of a pro-inflammatory stimulus on the 
peroxisomal compartment of M is to quantify the activation of M by investigating the 
activation cascade of known pro-inflammatory enzymes. In the literature the reaction cascade 
of macrophage cell lines as well as primary M to LPS incubation regarding the expression 
of inflammatory marker genes, such as iNOS, COX-2 and TNF, has been well described. 
However, these include only short incubation periods up to 24 h [245, 257-260]. 
Unfortunately, before the beginning of this thesis only scarce information was available on 
extended LPS incubation periods up to 72 h [261]. It was necessary to document protein 
alterations in the peroxisomal compartment after LPS treatment for time periods up to 72 h, 
because the half-life of peroxisome protein turn-over is approximately 3 days [242].  
The first experiments were performed to confirm a reliable induction of an inflammatory 
response in long term LPS incubation periods up to 72 h in RAW264.7. From the literature, it 
is known that the incubation of RAW264.7 cells with LPS leads to an increased expression of 
the differentiation and activation marker protein CD68 [262]. CD68 is present at the surface 
of the M plasma membrane as well as in endosomal membranes and it is thought to be 
involved in phagocytic processes. The results of this thesis (p. 59) showed indeed a clear 
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increase of CD68 protein abundance after LPS incubation, a positive confirmation that the 
RAW264.7 cells reacted appropriately to the LPS stimulation. Additionally, the effect of LPS 
on the mRNA induction of the pro-inflammatory marker genes COX-2, iNOS and TNFα in 
RAW264.7 MΦ was analysed [263-267]. Moreover, the expression of HO-1, an anti-
inflammatory protein, was investigated, which is known to be up-regulated by ROS produced 
during LPS stimulation [222].  
The steady state expression levels of corresponding mRNAs of RAW264.7 and primary M 
after LPS treatment at different incubation periods exhibited distinct patterns (p. 60). 
Compared to the increase of COX-2 and iNOS expression, induction of the TNF gene 
mRNA was less pronounced in RAW264.7 cells. The reason for this might be the different 
way of activation of the appropriate COX-2 or iNOS and TNF genes by distinct single 
stimuli [268]. These results on RAW264.7 M correspond very well to data from the 
literature on LPS stimulation and the expression of CD68 and mRNA expression levels of 
inflammatory mediators iNOS, COX-2 and TNF [269]. 
Overall, the results on RAW264.7 cells show that a pro-inflammatory response to LPS 
treatment occurs, suggesting that this cell line is a suitable model organism for investigating 
the effects of LPS on pro-inflammatory reactions. Therefore, RAW264.7 M seem to be well 
suited to study the alterations of the peroxisomal compartment therein. 
Parallel to the experiments with RAW264.7 M, a similar set of experiments was performed 
using isolated peritoneal M. The experiment confirmed that nearly all cultivated cells were 
CD68 positive (>98 %, p.62). However, due to the low cell number yield after isolation of 
primary peritoneal M these cells were used for RNA isolation and no Western blot analysis 
could be performed.  
Peritoneal M exhibited a strong increase of COX-2 and iNOS mRNA expression after 24 h 
and 48 h LPS treatment (p. 63). These results are in line with findings in the literature but it 
has to be mentioned that LPS incubation periods used in these publications were usually  
 24 h and differ from the LPS incubation periods in this thesis (> 24 h)[270]. In comparison 
to RAW264.7 M, peritoneal M show a stronger reaction regarding TNF mRNA 
expression after LPS treatment. Apparently, there are differences in pro-inflammatory 
signalling between primary murine M and the RAW264.7 cell line. Indeed, Rouzer et al. 
showed, that the RAW264.7 M are not able to autoregulate TNF release via the 
prostaglandin dependent pathway [271]. These differences must be taken into account, when 
the effects of LPS on the peroxisomal compartment of both cell types are discussed. However, 
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the results of this thesis show, that both cell types exhibited a strong inflammatory response to 
LPS at given time points, which allowed for the investigation of the effects of LPS treatment 
on the peroxisomal compartment in the RAW264.7 M cell line (especially also to analyse 
protein values) as well as in peritoneal WT M (for analyses on RNA level) at prolonged 
incubation periods. 
5.2.3 Effect of oxLDL on the peroxisomal compartment of RAW264.7 
Macrophage activation does not only occur after LPS-stimulation, but also by incubation with 
oxidized LDL particles. Therefore, the reaction of the peroxisomal compartment of 
RAW264.7 after oxLDL treatment was investigated. Physiologically, LDL is a complex 
mixture of protein and different types of lipids [272], that are oxidized under pathological 
conditions. It is well known that during pathogenesis of atherosclerosis low density 
lipoproteins (LDL) are trapped in the intima and are subject to oxidative modification, leading 
to the formation of oxidized LDL (oxLDL). The intimal oxLDL particles initiate an 
inflammatory response in epithelial cells leading to the attraction of blood monocytes to the 
site of LDL oxidation. The attracted monocytes invade the vessel wall, differentiate to 
macrophages and start to phagocytose the oxLDL in order to abolish the initial cause for 
inflammation. However, the overload of macrophages with oxLDL leads to foam cell 
formation, M cell death and progression and chronification of the pro-inflammatory 
response (for a review of the processes leading to atherosclerosis see [189]).  
Recognition of oxLDL and the underlying signalling pathways leading to the inflammatory 
responses have been well studied [273, 274]. However, the role of peroxisomes during these 
processes is not known. Since peroxisomes contain enzymes involved in ROS protection, e.g. 
catalase, as well as enzymes for bioactive lipid degradation, especially prostaglandin and 
leukotrien degradation, it is likely that oxLDL has an impact on the peroxisomal compartment 
of macrophages during the initiation and progression of atherosclerosis. Indeed, the oxidized 
lipid fraction of oxLDL activates PPARγ signalling in macrophages [275] and many 
peroxisomal genes contain PPREs in their corresponding promoter regions [225]. According 
to these considerations, the hypothesis for this thesis was generated that peroxisomes might 
play an important role in degradation of oxLDL in M.  
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Fig. 33 Schematic overview of oxLDL mediated signalling in M 
 
The different effects of LPS and oxLDL stimulation on the inflammatory response and the 
peroxisomal compartment of RAW264.7 cells might be explained by the different signalling 
pathways induced by these stimuli (p.70, p71). As described above, LPS recognition is 
mediated by TLR-4 and subsequently by NFκB signalling [276], whereas oxLDL is mainly 
recognised by a different set of receptors, such as scavenger receptor A (SR-A, =CD204) and 
CD36 [277, 278]. It is noteworthy, that Ohnishi et al. reported recently about the interference 
of SR-A and TLR-4 signalling, in a competitive manner which could explain the opposite 
effects of LPS and oxLDL on the peroxisomal compartment of M. However, in other 
publications it was described, that oxLDL could bind to TLR-4 [280], leading to an induction 
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of the inflammatory response [281]. Interestingly, Stewart et al. showed that CD36 initiates 
TLR-4/TLR-6 heterodimer formation after oxLDL recognition [282].  
It is known that PPARγ also influences TLR4 signalling (reviewed in [283]). Moreover, the 
lipid fraction of oxLDL effects PPAR signalling, more precisely PPARα and PPARγ. Despite 
that the effect of oxLDL on PPAR signalling in MΦ has been studied no information was 
available on oxLDL effect on the peroxisomal compartment [284]. This thesis provides the 
first direct evidences that the peroxisomal compartment is affected by oxLDL treatment. The 
effect of PPAR signalling on the peroxisomal gene expression of β-oxidation enzymes and 
the overall compartment has been well described for other cell types and organ systems 
revealing also a strong cell type specific differences [212, 285]. Taken together, it is most 
likely that oxLDL incubation of M indeed leads to PPAR mediated changes in the 
peroxisomal compartment of M. The exact mechanisms of these processes, however, have 
to be clarified in future experiments  
Although, these oxLDL results are very remarkable, it has to be mentioned that working with 
oxLDL has several drawbacks. LDL has to be isolated from donor blood samples in high 
amounts and has to be oxidised to oxLDL subsequently. Problems are therefore the supply 
with donor blood samples and the unpredictable composition of the generated oxLDL due to 
non-standardised oxidation events happening during the regular procedure of oxLDL 
preparation. LPS on the other hand is a well-defined single molecule, easy to order in high 
purity and to work with. Additionally, LPS incubation of RAW264.7 led to a much more 
pronounced induction of a pro-inflammatory response. Therefore, it was decided to prioritise 
LPS-experiments and to analyse the influence of LPS on the peroxisomal compartment of 
M in detail. The effect of oxLDL on the peroxisomal compartment of M will be 
investigated in future studies, which certainly will provide valuable information about the role 
of peroxisomes in M during the molecular pathogenesis of atherosclerosis.  
 
5.3 Peroxisomes in Macrophages  
Although the organelle “peroxisome” itself was described for the first time more than 50 
years ago [3], very little is known about its physiological role in cells of the immune system. 
Khan et al. described the influence of LPS on the peroxisome function in rat liver and 
emphasized only on a role of Kupffer cell released TNF influencing especially peroxisomal 
β-oxidation [185, 186]. Since peroxisomes harbour many antioxidative enzymes and are 
involved in plasmalogen biosynthesis as well as the degradation of a variety of signalling and 
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bioactive lipid mediators, it can be hypothesised that peroxisome metabolism is involved in 
the regulation of the inflammatory response by influencing ROS level and metabolising lipid 
based pro- as well as anti-inflammatory mediators. 
Karnati and Baumgart-Vogt discovered the presence of an abundant peroxisomal 
compartment in alveolar M and described the role of peroxisomes during the physiological 
functions of this cell type [1, 286]. Moreover, during the experimental work of this thesis 
Dixit et al. discovered very recently that peroxisomes are involved in antiviral defence 
indicating an important role of peroxisomes in the innate immune response [287].  
5.3.1 Effect of LPS on the peroxisomal compartment of RAW264.7 M 
and primary mouse M 
After the confirmation of the LPS-induced pro-inflammatory response in RAW264.7 M and 
primary mouse M, the effect of LPS treatment on the peroxisomal compartment in these cell 
types was investigated. LPS effects on catalase and PPAR were described in the literature in 
rat liver by Beier et al. [288]. Furthermore, Contreras et al. reported a reduced β-oxidation 
activity in rat liver after LPS treatment [186]. From the same lab, Khan and colleagues 
showed that deletion of Kupffer cells from rat liver normalized the situation in the liver after 
LPS treatment [185], linking the observed LPS mediated effects on liver peroxisomes partly 
to the cytokine release (e.g. TNF) of liver specific M, the Kupffer cells. Moreover, Paintila 
et al. described the effects of LPS on peroxisomal proteins involved in myelin synthesis in the 
developing murine brain revealing that LPS and TNF led to impaired peroxisomal β-
oxidation and elevated ROS generation via inhibition of PPAR signalling [289]. Ahlemeyer 
et al., colleagues from our group, reported about the destructive effect of elevated ROS levels 
after Pex11β gene KO on peroxisome and mitochondrial function, leading to apoptosis of 
neurons [72]. It is likely that LPS induced reduction of peroxisomal β-oxidation is 1) a cell 
type specific phenomenon depending on the abundance of TLR4 as well as corresponding 
signalling pathways and 2) is further enhanced by the release of pro-inflammatory cytokines 
(e.g. TNF) which varies in individual cell types. However, the question how and when 
inflammatory processes lead to impairment or reconstitution of peroxisomal function is still 
not answerd. 
In this thesis it was revealed that in RAW264.7 MΦ genes of peroxisomal proteins involved 
in ROS degradation (catalase), β-oxidation (thiolase, ABCD3) and peroxisomal proliferation 
(DLP-1, Pex11α) are strongly influenced by the LPS incubation (p. 64). Comparing these 
results with the results of the primary peritoneal MΦ, alterations in the peroxisomal 
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compartment of peritoneal M are not as pronounced as in RAW264.7 MΦ (p. 65). 
Nevertheless, a similar pattern of mRNA alterations was observed in both cell types. These 
differences might be related to the different origins of the cells. RAW264.7 is an immortalised 
cell line for long time cultivation while primary M were freshly isolated (from lung, 
peritoneal cavity or differentiated from bone marrow derived stem cells).  
In contrast to the observed decrease of peroxisomal β-oxidation enzyme mRNA expression, 
the gene for peroxisomal biogenesis protein Pex14 exhibited the same mRNA expression 
level in LPS treated and untreated cells and its corresponding protein PEX14p was increased 
after LPS treatment. Additionally, increased Pex11α and DLP-1 mRNA expression after LPS 
treatment at later time points (> 24 h) was observed. Unfortunately Western blot analysis for 
Pex11 proteins were not possible although several different antibodies from the group of 
Steve Gould (John Hopkins University, Baltimore, USA) as well as from different companies 
have been tested in this thesis. No antibody against Pex11 proteins gave reliable results and 
the commercial available antibodies described as “working well” recognized non-specific 
proteins at a similar kD range, shown by Ahlemayer et. al. in supplementary materials [72]. 
Therefore, only the functional effect of LPS on Pex11α- and DLP-1-mediated peroxisome 
alterations and proliferation were determined indirectly by immunofluorescence staining of 
RAW264.7 MΦ using an anti Pex14p antibody, providing excellent staining for M 
peroxisomes (p. 68) [1]. As revealed by the immunofluorescence stainings, the peroxisome 
number was indeed increased after LPS treatment (p. 65), which is in line with the increased 
expression of Pex11 and DLP-1 mRNA after prolonged LPS incubation periods. These 
results suggest that LPS treatment leads to peroxisome proliferation, because both genes 
encode proteins involved in peroxisomal fission [212, 239, 255]. It is likely that after an initial 
reduction of metabolic active peroxisomal proteins in the early stage of the pro-inflammatory 
response leading the accumulation of PPARγ activating substrates, peroxisomes proliferate 
and reconstitute their protein composition at the late inflammation stage, involved in the 
resolution phase of the acute inflammatory processes.  
This would also imply that a dysfunction of Pex11p or peroxisomal metabolic pathways 
would lead to a delay of the resolution or to a chronification of inflammatory processes. 
Indeed, significant alterations of pro-inflammatory reactions were found in Pex11 KO 
animals as discussed in chapter 5.4. 
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5.3.2 Effect of pharmacological inhibitors on the inflammatory response 
and the peroxisomal compartment in RAW264.7 
The results discussed above led to the hypothesis that LPS-dependent signalling pathways 
lead to the influence on the gene activity and expression of peroxisomal matrix proteins and 
alterations observed on peroxisomal fission via the TLR-4/NFB followed by TNF release 
and subsequent TNF-R dependent signalling. Beier et al. have already shown in rat liver, that 
TNF- influences PPAR mediated peroxisome metabolism [288]. In line with the results of 
this thesis, Contreras et al. have suggested that LPS dependent cytokine release might be 
responsible for impaired peroxisomal β-oxidation in rat liver, implicating also an autocrine 
stimulation of the liver specific M, the Kupffer cells via TNF. To test this 
hypothesis, we used pharmacological inhibitors against TLR-4, NFB and TNF-R (see Fig. 
34). The TNF-R inhibitor was included because TNF is one of the most important 
inflammatory cytokine released during the inflammatory response of M.  
The initial experiment determined the working concentrations for the pharmacological 
inhibitors (p 74): CLI-095 against the TLR-4 receptor, celastrol against NFB and SPD-034 
against TNF-R. Indeed, it was noted that the recommended working concentrations by the 
corresponding manufacturer of celastrol and SPD-034 for short incubation periods were 
highly toxic to the RAW264.7 cells at prolonged incubation periods up to 72 h. CLI-095 
could be used at the proposed concentration of 18.0 µM without inducing a cytotoxic effect. 
In contrast, celastrol and SPD-034 showed a dose dependent increase in cytotoxicity. These 
effects might be related to the extended incubation times up to 72 h. Since NFB-activation is 
also involved in pathways related to cell survival [290], a prolonged inhibition of this 
pathway might lead to increased cell death. The reason for toxicity of SPD-034 is less clear. 
Non-toxic concentrations were applied for further experiments, bearing in mind that lower 
concentrations of celastrol and SPD-034 might also influence their inhibitory capacities on 
appropriate signalling pathways. 
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Fig. 34 Schematic overview of the LPS induced pro-inflammatory signalling cascade in M and 
corresponding inhibitors.  
(1.) First step of LPS induced M activation is LPS/TLR4 binding.  
CLI-095 inhibits LPS/TLR4 binding. (2.) The most critical step in M is the release of NFB from IB and 
its translocation into the nucleus. NFB release is inhibited by celastrol. (3.) LPS signalling leads to the 
release of vesicular TNF into the interstitium, acting as autocrine and paracrine messenger. The binding of 
TNF with its receptor TNF-R is inhibited by SPD-034. 
 
The inhibitory capacities of the compounds and the effects of their conincubation with LPS 
were determined by COX-2 or iNOS mRNA expression analyses which revealed strong 
inhibitory capacities for all compounds. The inhibitors abolished (CLI-095, Celastrol) or 
reduced (SPD-034) COX-2 and iNOS mRNA expression after LPS treatment  
(p. 75).  
These results indicated that there was a direct effect of LPS on the abundance of peroxisomal 
proteins during the TLR-4 and NFB mediated inflammatory response. Moreover, it could be 
shown, that also the TNF release was in an auto-/paracrine manner involved in mediating 
the effects in peroxisomal gene expression levels and protein abundance alterations (p. 76). 
As described above, it is well known, that inflammatory processes do also influence PPAR 
signalling [283], which is directly linked to peroxisomal gene expression and metabolism [5]. 
According to these reports, PPARα is reduced during inflammation [80], whereas PPARγ is 
increased [82]. Future studies are necessary to clarify the role of PPAR mediated regulatory 
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mechanisms on alterations of individual peroxisomal enzymes and peroxisome proliferation 
and the activation of the NFB and TNF signalling pathways. It is most likely, that at least 
some of the effects on the peroxisomal compartment are mediated by distinct PPARs in the 
M. It is plausible that changed PPAR and PPARγ signalling during the inflammatory 
response have an impact on the peroxisomal compartment. However, the effect of the 
inhibitors on peroxisomal protein abundance could also be interpreted that peroxisomal genes 
might be directly regulated by NFB mediated signalling. This would have a strong impact on 
the role of peroxisomes during inflammatory processes. Because peroxisomes contain 
enzymes involved in the degradation of pro-inflammatory mediators, e.g. eicosanoids, 
peroxisomes could play an important role during the resolution phase of inflammation by 
degrading these pro-inflammatory mediators.  
Doctoral Thesis  Andreas Kollas 
Institute of Anatomy and Cell Biology   
 
99 
5.4 Effect of PEX11 KO on the inflammatory response of primary 
mouse M 
As described in chapter 5.3, LPS exhibited significant effects on the peroxisomal 
compartment of M. In addition to metabolic changes, the induction of PEX11 mRNA 
expression was very prominent, which is in line with the increased number of peroxisomes 
induced in later phase of LPS treatment. To gain insights on the effects of a Pex11 
dysfunction on the inflammatory response, primary M isolated from Pex11 KO mice with 
a C57Bl/6J background were analysed. 
Pex11 KO mice are the only knockout mice with a general peroxisomal biogenesis defect 
that survive until adulthood [212], wherefore M isolation from these adult knock out 
animals was indeed possible. In contrast to Pex11 KO animals, KO mice with other 
peroxisomal biogenesis defects die during the first days of life [72]. Even KO mice of the 
Pex11 gene, encoding a protein of the same family, possess a severe phenotype, leading to 
death immediately after birth. 
Peroxisomes in M of PEX11 KO mice were larger and less numerous compared to the WT 
M (p. 79). This is in line with previously published data in fibroblasts, neurons and 
hepatoma cells in mouse liver that reported about a role of PEX11 in peroxisomal 
proliferation or altered peroxisomal fission due to changes in nutritional factors [21, 212, 
239]. Pex11 KO M showed an increase of apoptotic/necrotic cell death after LPS 
treatment, which was quantified with a LDH-assay (p. 81). The results of these experiments 
suggest that the disruption of the Pex11 gene does influence the general cell survival of M 
under LPS-induced stress conditions. Interestingly, alterations of mitochondrial cristae have 
been reported from our group in the liver of Pex11 KO mice [212] and it is known, that high 
levels of oxidative stress can induce the intrinsic apoptosis pathway via mitochondrial 
cytochrom c release [295-297]. Therefore, Western blot analyses of Pex11 deficient 
BMDM, using an antibody against both cleaved forms of activated caspase-3 were performed 
(p. 83), which revealed an increase of caspase-3 activation in LPS treated PEX11 KO M 
compared to WT M, corroborating the microscopical results [298, 299]. Moreover, the 
mRNA level for Bad, a marker of intrinsic apoptosis via the mitochondrial pathway [300], 
was elevated in PEX11 KO M, further supporting these results (p. 82).  
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Apparently PEX11 KO M are more susceptible to intrinsic cell death than WT M under 
LPS induced stress. The source of this stress is among other things oxidative stress after  
TLR-4 mediated oxidative burst [301, 302]. 
Interestingly, mRNA-expression levels of the pro-inflammatory marker genes COX-2 and 
iNOS were highly elevated after LPS-treatment in Pex11 KO Min comparison to 
corresponding levels of LPS-stimulated WT M. This suggests that the Pex11 KO affects 
the LPS-response in M. Moreover, sex specific differences were observed in the reaction of 
Pex11 KO M originating from male or female KO mice to LPS stimulation. Female 
animals exhibited higher values in both, untreated and LPS-treated conditions than Pex11 
KO M from male mice, regarding the mRNA expression levels of COX-2 or iNOS (p. 84). 
Indeed, it has been reported that sex specific differences have a strong impact on the function 
of the mammalian innate immune system [303]. Furthermore, recently Rettew et al. have 
shown in mouse that testosterone led to a decrease in TLR-4 expression in mouse M [304]. 
In the same line of evidence Rettew and his coworkers could show, that estrogens regulate the 
TLR-4 expression on M in an in vivo mouse model [305].  
However, how the Pex11 gene deficiency influences the TLR-4 signalling cascade, leading 
to changed COX-2 and iNOS levels is not clear. The KO of Pex11 could have an impact on 
the degradation of signalling lipid mediators (e.g. arachidonic acid), leading to an increased 
pro-inflammatory response and a higher and prolonged ROS level induced bythe levated level 
of pro-inflammatory eicosanoids (prostaglandins and leukotriens), strongly affecting the 
resolution phase of the inflammatory processes.  
According to these results, peroxisomes might play an important role in the metabolic 
regulation of macrophage activity. 
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6. Conclusion and outlook 
In this thesis the peroxisomal compartment in the murine macrophage cell line RAW264.7 
and in murine primary macrophages has been characterised. The results of this dissertation 
provide first evidences for an important role of peroxisomes in innate immunity of 
macrophages during their reaction against the pro-inflammatory stimulus LPS. Interestingly, 
opposite effects were noted on the peroxisomal compartment by treatment with oxLDL. 
Moreover, major alterations were noted at pro-inflammatory reactions in M with PEX11 
defect. Pex11 induction and peroxisome proliferation and reconstitution of peroxisomal 
enzyme levels occur in the late phase ( 48 h) of LPS-stimulation. Taken together the results 
of this thesis suggest that peroxisomes are involved in the regulation of the pro-inflammatory 
response and the resolution of inflammatory processes. The observed processes could play an 
important regulatory role during chronic inflammatory diseases such as atherosclerosis, 
Alzheimer’s disease or liver cirrhosis. This might be related to impaired peroxisome function 
on several levels: 1) impaired ROS defence leads to increased oxidative stress and prolonged 
inflammatory processes. 2) disturbed detoxification of xenobiotics and changed metabolism 
of anti-inflammatory signalling molecules (e.g. prostaglandins). 
To gain a deeper understanding of the role of peroxisomes during the inflammatory process of 
M, further studies have to be performed. Life cell imagine of tagged peroxisomes in M 
will reveal the kinetics of peroxisome proliferation during M activation. Chip based gene 
expression experiments (microarray analysis) will give an overview of the gene expression 
pattern under peroxisome KO conditions and will provide valuable information about the 
expected corresponding protein expression. These studies could be combined with si/sh RNA 
experiments in macrophage cell lines, to analyse the influence of other peroxisomal gene 
knock outs on the inflammatory response of M. Future in vivo experiments with the Pex11 
mouse model will clarify, whether peroxisomes are essential organelles in the innate immune 
defence against bacterial infections and if Pex11 animals are more prone to severe septic 
shock. Indeed the Pex11 KO mouse model also provides an ideal tool to study the 
consequences of peroxisome disturbances on signalling pathways of distinct cell types of the 
innate immune system and will open new perspectives regarding the resolution phase and 
chronification of inflammatory processes. 
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7. Summary  
 
Macrophages are, as part of the innate immune system, at the first line of defense against 
invading pathogens and intrinsic inflammatory factors. Although it is known that 
macrophages contain peroxisomes which fulfill important functions in cell metabolism, e.g. 
ROS degradation or lipid metabolism, before the beginning of this thesis, nothing was known 
about the role of peroxisomes in macrophages. 
In this thesis, all methods available were established to study peroxisomes in macrophages. 
Pro-inflammatory reactions were induced by LPS or oxidized LDL. Moreover, LPS-mediated 
effects on macrophages were characterized under conditions of peroxisomal dysfunction. 
Establishment of an optimal protocol for subcellular fractionation by differential 
centrifugation for the isolation of enriched peroxisomal fractions revealed that freezing of the 
macrophage cell samples was beneficial for the homogenization procedure and necessary for 
the best peroxisome recovery. Only these enriched peroxisome fractions enable the study of 
less abundant peroxisomal metabolic proteins, such as the peroxisomal thiolase. Moreover, 
during the establishment of an optimal protocol for long term LPS treatment, it was noted, 
that serum addition to the incubation medium was essential for macrophage long-term 
survival. Serum-free incubation, as generally used in the literature, exerted negative effects on 
cell survival and the peroxisomal compartment. 
After LPS treatment, RT-PCR and Western blot analyses as well as immunoflourescence 
studies with antibodies against POL proteins revealed tremendous changes in the peroxisomal 
compartment and related genes. Up to 24 h β-oxidation enzymes, the H2O2 degrading catalase 
as well as the peroxisomal biogenesis protein PEX11α were strongly reduced. In contrast, the 
PEX13 gene was hardly influenced and PEX14 not altered at all. Since Pex14p was not 
changed, an antibody against this protein was used as an ideal marker to identify peroxisomes 
after LPS treatment. Immunofluorescence-based studies on peroxisome morphology revealed 
a significant increase in numerical abundance of peroxisomes after long-term LPS incubation 
(> 48 h). Moreover, increased PEX11α induction preceded the peroxisomal proliferation and 
the protein levels of catalase as well as β-oxidation enzymes were almost reconstituted at late 
incubation times. This suggests an important role of peroxisomal metabolism in the resolution 
of inflammatory processes in macrophages. Furthermore, the underlying signaling pathway 
was investigated with specific inhibitors against TLR-4, NFκB and TNF-R1/2. The results 
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revealed that the peroxisomal response was mediated by the TLR-4/NFκB pathway, as well as 
the TNF-R pathway in the early phase of LPS-treatment. 
Incubation of macrophages with oxidized LDL (oxLDL) induced opposite effects on the 
peroxisomal compartment of macrophages, increasing protein levels of catalase and thiolase. 
This suggests that the peroxisomal compartment in macrophages is activated during clearing 
of oxidized lipids and would lead to cell protection against oxLDL-mediated lipotoxicity and 
oxidative stress, possibly preventing or retarding foam cell formation during the development 
of atherosclerosis. 
Finally, experiments focused on LPS-induced effects under peroxisomal dysfunction 
conditions in primary macrophages of Pex11α knockout mice, since this gene was severely 
affected in distinct phases of LPS-treatment. Indeed increased macrophage cell death and 
activation of caspase-3 was observed, accompanied by increase of Bad mRNA expression, 
suggesting an activation of the intrinsic mitochondrial apoptosis pathway. Moreover, sex-
specific differences in expression of pro-inflammatory marker genes were noted under steady-
state conditions as well as under LPS-stimulation, revealing a stronger reaction of 
macrophages isolated from female mice.  
Taken together, the results of this thesis indicate that peroxisomes are abundant in 
macrophages and fulfill important metabolic tasks during macrophage activation by distinct 
pro-inflammatory stimuli. As shown in Pex11α gene KO experiments, peroxisomal 
dysfunction severely alters pro-inflammatory mediators and might lead to prolongation or 
chronification of inflammatory processes. In this respect, peroxisomal metabolic pathways 
play an important role for the protection of macrophages against cell death during activation 
and anti-pathogenic response and the resolution of inflammatory processes. Since the 
observed effects seemed to be part of a general defense mechanism in M, it is likely, that 
peroxisomes play also a role in a variety of chronic inflammatory diseases, such as liver 
cirrhosis, neuro-degenerative diseases like Alzheimer’s disease or atherosclerosis. 
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8. Zusammenfassung 
 
Makrophagen stehen als Teil der angeborenen Immunabwehr an vorderster Front der 
körpereigenen Verteidigung gegen eindringende Pathogene und intrinische inflammatorische 
Faktoren. Obwohl bekannt ist, dass Makrophagen Peroxisomen enthalten, die wichtige 
Funktionen im Zellmetabolismus ausführen, z.B. ROS-Abbau oder Lipid β-Oxidation, war zu 
Beginn dieser Dissertation keine Fakten über die Rolle von Peroxisomen in Makrophagen 
bekannt. 
In der vorliegenden Arbeit wurden alle Methoden etabliert, um Peroxisomen in Makrophagen 
zu untersuchen. Die Aktivierung der Makrophagen wurde durch Inkubation mit LPS bzw. mit 
oxLDL ausgelöst. Darüber hinaus wurden LPS-induzierte Effekte in Makrophagen mit 
defekten Peroxisomen untersucht. 
Die Etablierung eines optimalem Protokolls zur subzellularen Fraktionierung und Isolierung 
einer angereicherten Peroxisomenfraktion mit Hilfe von differentieller Zentrifugation 
erbrachte, dass Einfrieren der Zellproben bessere Ergebnisse bei der Homogenisierung lieferte 
und notwendig war, um eine ideale Anreicherung der Peroxisomen zu erzielen. Nur durch die 
Verwendung der angereicherten Peroxisomenfraktion konnten auch peroxisomale Enzyme 
analysiert werden, die nur in geringer Menge exprimiert werden, wie z.B. die peroxisomale 
Thiolase. Während der Etablierung eines optimalen Protokolls zur Langzeitinkubation der 
Makrophagen mit LPS zeigte sich, dass die Zugabe von Serum ins Inkubationsmedium 
essentiell notwendig war, um das Überleben der Zellen zu sichern. Des weiteren 
beeinträchtigte die Verwendung von serumfreiem Medium, wie sie in der Literatur angegeben 
wird, die Peroxisomenaktivität. 
RT-PCR und Western Blot-Analysen sowie Immunofluoreszenz-Studien erbrachten 
tiefgreifende Veränderungen des peroxisomalen Kompartments nach LPS Behandlung. Nach 
24 h wurde die Genexpression von β-Oxidationsenzymen, der H2O2 abbauende Katalase und 
des peroxisomalen Biogeneseproteins PEX11α drastisch reduziert. Dagegen war die 
Expression des PEX13 Gens kaum und die des PEX14 nicht beeinflusst. Da die LPS 
Behandlung PEX14 nicht beeinträchtigte, wurde ein Antikörper gegen Pex14p als idealer 
Marker zum Nachweis der Peroxisomen nach LPS-Behandlung verwendet. Versuche -  
basierend auf Immunofluoreszenzfärbungen von peroxisomalen Proteinen zum Nachweis des 
Organells - ergaben, dass sich die Peroxisomenanzahl nach Langzeitbehandlung mit LPS  
(48 h) signifikant vermehrte. Zudem ging der Peroxisomenproliferation ein Anstieg der 
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Pex11α-Genexpression voraus und die Proteinspiegel von peroxisomalen  
β-Oxidationsenzymen und Katalase wurden weitgehend wiederhergestellt. Diese Ergebnisse 
weisen auf eine Rolle des peroxisomalen Metabolismus in der Auflösung inflammatorischer 
Prozesse in Makrophagen hin. Weiterführend wurden die zugrunde liegenden Signalwege 
untersucht. Verwendet wurden spezifische Inhibitoren gegen TLR-4, NFκB sowie TNF-R. 
Die Ergebnisse zeigten, dass die peroxisomale Reaktion auf die LPS-Behandlung durch den 
TLR-4/NFκB Signalweg sowie durch TNF-R, insbesondere in frühen Zeitpunkten, vermittelt 
wurden.  
Die Behandlung von Makrohagen mit oxidiertem LDL (oxLDL) zeigte entgegengesetzte 
Effekte wie die LPS-Behandlung. Eine Western Blot-Analyse erbrachte erhöhte 
Proteinmengen an Katalase sowie Thiolase. Dies könnte ein Hinweis darauf sein, dass das 
peroxisomale Kompartment in Makrophagen während der Beseitigung von intimalem oxLDL 
aktiviert wird. Damit könnte der Schutz von Makrophagen vor Lipotoxizität und oxidativen 
Stress verbunden sein, um die Schaumzellbildung zu verhindern 
Zuletzt konzentrierten sich die Versuche auf den Einfluss einer peroxisomalen Dysfunktion 
auf die LPS indizierte Makrophagenaktivierung. Dazu wurden Makrophagen aus PEX11α KO 
Mäusen isoliert, da sich gezeigt hatte, dass die PEX11α-Expression stark von der LPS-
Behandlung beinflusst wird. Tatsächlich wurden in PEX11α KO Makrophagen ein erhöhter 
Zelltod und die Aktivierung von Caspase-3 beobachtet, verbunden mit einer erhöhten Bad 
mRNA-Expression in KO-Makrophagen, was darauf hindeutet, dass der intrisiche 
mitochondriale Apoptoseweg vermehrt induziert ist. Des Weiteren traten 
geschlechtsspezifische Unterschiede in der Reaktion auf LPS-Behandlung auf, was sich durch 
eine stärkeren Expression pro-inflammatorischer Marker in Makrophagen von weiblichen 
PEX11α KO Mäusen äußerte.  
Zusammenfassend läßt sich feststellen, dass Peroxisomen in Makrophagen stark ausgeprägt 
vorkommen und dort wichtige Funktionen während der Aktivierung von Makrophagen durch 
verschiedene Stimuli wahrnehmen. Wie durch Versuche an PEX11α-KO-Mäusen gezeigt 
wurde, verändert die peroxisomale Dysfunktion gravierend die Expression  
pro-inflammatorischer Marker und könnte zur Verlängerung oder zur Chronifizierung 
inflammatorischer Prozesse führen. Daher erfüllt der peroxisomale Metabolismus wichtige 
Funktionen im Schutz von Makrophagen vor frühzeitigem Zelltod während ihrer Aktivierung 
und der Pathogenabwehr. Der hier beobachtete Effekt könnte Teil eines generellen 
Schutzmechanismus in Makrophagen sein. Daher ist es wahrscheinlich, dass Peroxisomen 
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ebenfalls bei chronischen Entzündungskrankheiten wie Leberzirrhose, neurodegenerativer 
Erkrankungen, z.B. Alzheier, oder Atherosklerose, eine Rolle spielen. 
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9. Abbreviations 
 
Temperatue  
°C   Grad Celsius 
Time 
h   hour 
m   minute 
s   second 
 
Weight 
g   gram 
mg   milli gram 
µg   micro gram 
 
Volume 
l   liter 
ml   milliliter 
µl   microliter 
 
Other 
BSA   bovine serum albumin 
Cox-2    cyclooxygenase-2 
ddH2O   double deionised water 
DMEM  Dulbeccos modified Eagle`s medium  
EDTA   ethylenediaminetetraacetic acid 
ERK    extracellular signal-regulated kinase 
FCS   fetal calf serum 
GAPDH   glyceraldehydes-3-phosphate dehydrogenase 
HB   homogenization buffer 
IB   inhibitor of NF-κB 
JNK   c-jun N-terminal kinase 
LPS   lipopolysaccharide 
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MΦ   macrophage 
MAPKs  mitogen activated protein kinases 
MTT    3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NF-κB   nuclear factor-κB 
NO    nitric oxide 
PBS   phosphate buffered saline 
PMA    phorbol myristate acetate 
ROS   reactive oxygen species 
RT   room temperature 
RPMI-1640  Roswell Park Memorial Institut 1640 
SDS   sodium dodecyl sulfate    
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TBS   tris buffered saline 
TLR   toll-like receptor 
TNFα   tumour necrosis factor-α 
TPA   2-O-tetradecanoylphorbol-13-acetate 
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habe ich die Grundsätze guter wissenschaftlicher Praxis, wie sie in der „Satzung der Justus-
Liebig-Universität Gießen zu Sicherung guter wissenschaftlicher Praxis“ niedergelegt sind, 
eingehalten sowie ethische, datenschutzrechtliche und tierschutzrechtliche Grundsätze 
befolgt. Ich versichere, das Dritte von mir weder unmittelbar noch mittelbar geldwerte 
Leistungen für Arbeiten erhalten haben, die im Zusammenhang mit dem Inhalt der 
vorgelegten Dissertation stehen, oder habe diese nachstehend spezifiziert. Die vorgelegte 
Arbeit wurde weder in Inland noch im Ausland in gleicher oder ähnlicher Form einer anderen 
Prüfungsbehörde zum Zweck einer Promotion oder eines anderen Prüfungsverfahrens 
vorgelegt. Alles aus anderen Quellen und von anderen Personen übernommene Material, das 
in der Arbeit verwendet wurde oder auf das direkt Bezug genommen wird, wurde als solches 
kenntlich gemacht. Insbesondere wurden alle Personen genannt, die direkt und indirekt an der 
Entstehung der vorliegenden Arbeit beteiligt waren. Mit der Überprüfung meiner Arbeit durch 
eine Plagiatserkennungssoftware bzw. einer internetbasiertes Softwareprogramm erkläre ich 
mich einverstanden. 
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